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ABSTRACT 
 
 
There is a dearth of validated self-efficacy (SE) measures in the field of 
preventive oncology. The objective of this study is to describe the development and 
validation of a measure to assess patients’ perceived ability to obtain the recommended 
care following an abnormality suspicious for breast cancer.  Guided by a social cognitive 
theory framework, a 51-item measure was developed to explore perceived capability to 
obtain follow up care under a number of barriers. A multi-step process was utilized to 
assess the instrument’s psychometric properties. First, cognitive validity assessments 
with experts were conducted, and these aided in the wording refinement of several items. 
An exploratory factor analysis was performed, and a 4-factor solution emerged 
containing factors related to barriers to care such as costs, transportation, structural and 
communication barriers. Reliability analyses were conducted for the total scale and 
subscales. Then, relationships between theoretically-related constructs were explored to 
assess convergent validity (self-efficacy and outcome expectations, perceived control), 
and divergent validity (self-efficacy and depression). Findings provide evidence of both 
convergent and discriminant validity. This multi-step process aided in the reduction of 
the scale to 12 validated and reliable items.   
                 
 
 
  
 
 
 
INTRODUCTION 
 
Cancer is the second leading cause of death in the United States (Heron et al., 
2009). In fact, 1 of every 4 deaths is attributed to cancer, and in 2009, 1,500 people died 
each day due to cancer. Breast and colorectal cancers are in the top three cancers that 
affect both men and women. In 2009, the total number of new cases of breast and 
colorectal cancer was estimated at 194,280 and 146,970 for both sexes respectively 
(American Cancer Society, 2009).  
Breast cancer is the most commonly diagnosed type of cancer in women. In 2009, 
192,370 new cases of invasive breast cancer were estimated to occur in the US, and 
12,650 new cases in Florida alone. Incidence rates have slightly (2.2%) decreased in the 
last twenty years. Nevertheless, 40,170 breast cancer deaths in the US and 2,730 in 
Florida were estimated, making breast cancer the second leading cause of death in 
women in 2009.   
Colorectal cancer is the third most common cancer for both men and women. In 
2009, 146,970 new cases of colorectal cancer were estimated in the US, and 10,420 in 
Florida alone. Incidence rates for colorectal cancer have also decreased in the last two 
decades, 46.4 cases per 100,000 population in 2005, compared to 66.3 in 1985. This is 
also due in part to an increase in screenings. As incidence rates decreased, so have 
mortality rates; there was a 4.3% decrease per year from 2002 to 2005 for men and 
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 women. In 2009, there were 49,920 deaths in the US, and 3,460 in Florida for colorectal 
cancer (American Cancer Society, 2009).   
As shown by the cancer statistics, for breast and colorectal cancer incidence and 
mortality rates have declined in the last 20 years. This is in part attributed to the increase 
in screenings for early detection and treatment of cancers. For instance, bolstering 
mammography utilization may prompt early detection of breast cancer, and increasing 
colorectal cancer screenings may contribute to the detection and removal of polyps before 
they develop into cancer. Thus, promotion and improvements on early detection are 
essential to reduce cancer figures.  
Unfortunately, cancer figures are not as promising when rates for underserved and 
minority populations are examined. Individuals from minority groups are more likely to 
have higher incidence rates from certain cancers than their white counterparts (National 
Cancer Institute, 2007). In addition, poor and medically underserved populations have 
higher cancer mortality rates and lower survival rates (American Cancer Society, 2008; 
National Cancer Institute, 2007). In fact, African-American women are 1.2 times more 
likely to die from cancer than white women (Gullatte, Phillips, & Gibson, 2006; Ward E, 
Jemal A, Cokkinides V, & al., 2004). Studies have shown that only 33.7% of immigrant 
women have had a mammogram within the last year, and only 41.4% within the last two 
years (Ward E, et al., 2004). Other studies provide evidence that women who have 
migrated to the US have lower rates of breast self-examination adherence when compared 
to their US-born counter parts (Borrayo & Guarnaccia, 2000). The contributing factors to 
these racial health disparities are complex, and it is difficult to single out a determining 
cause for it. Socioeconomic status (SES) is one of the most influential factors in this 
2 
 
 issue. However, a person’s SES, i.e. income, education level, occupation, etc, is often tied 
to other contributing factors to racial/ethnic disparities, such as access to care and barriers 
(National Cancer Institute, 2007). 
The health care system is complex and may be challenging for many patients. 
Cancer screenings as mentioned above are essential in reducing cancer mortality. 
However, navigating the health care system to obtain the needed care after an abnormal 
cancer screening may prove to be quite challenging for many people.  Patients are faced 
with several barriers, and the literature has explored and documented many of these 
variables including language and literacy barriers (Brown et al., 2011; Wolff et al., 2003), 
transportation (Wolff, et al., 2003), distance to health care providers, lack of insurance 
(Borrayo & Guarnaccia, 2000), financial difficulties, and self-efficacy (Carpenter & 
Colwell, 1995). 
 
Self-Efficacy 
Self-efficacy is a construct, which stems from the Social Learning Theory (SLT), 
developed by psychologist Albert Bandura (Bandura, 1986). Bandura began examining 
and publishing his work on SLT in the early 60’s. He published his book Social 
Foundations of Thought and Action: A Social Cognitive Theory in 1986, and began 
exploring a construct that has now become a staple, and vital component, in most theories 
of health behavior. The Health Belief Model, for instance, incorporates self-efficacy in 
the model by addressing barriers to action (Becker & Rosenstock, 1987). The Theory of 
Reasoned Action was extended to the Theory of Planned Behavior, by including a 
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 perceived behavioral control component (Ajzen, 1991). Other health behavior models 
have incorporated self-efficacy as an essential component, as well.  
According to Bandura, perceived self-efficacy refers to an individual judgment of 
their capability to execute a behavior (Bandura, 1982a). This construct has been widely 
explored as perceived capabilities function as determinants of human behavior. Bandura 
asserted that people often avoid activities that they believe are hard to manage, and 
undertake those activities that they judge as more manageable. Thus, judgments of 
capability can determine the amount of effort that individuals put into a certain behavior 
and how long they persist in the face of barriers (i.e. obstacles or aversive experiences). 
Bandura’s theory also explored predictability of behavior based on perceived self-
efficacy. His early research supports that perceived self-efficacy was a stronger predictor 
of future behaviors than performance attainment. In other words, he found that people are 
more influenced by how they perceive their success than their actual success (Bandura, 
1982a). His early work sparked interest in many research arenas.  
Self-efficacy has been explored in the education arena, as a mediator of academic 
achievement (Rosenholtz & Rosenholtz, 1981); in the management arena to identify 
factors that interfere with work type and work quality (King, Le Bas, & Spooner, 2000); 
and in the disaster recovery arena to assess capabilities to manage recovery demands 
following a natural disaster (Hyre et al., 2008). Assessments of self-efficacy in these 
different areas have demonstrated that perceptions of capability in response to demands 
of situations within a context are notably useful. Moreover, these assessments can 
potentially benefit the quality of outcomes in their respective contexts.  
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 Similarly, the health area has explored self-efficacy in the context of health 
behavior. Behavioral change is facilitated by a strong sense of personal efficacy (Bandura 
1982a). Self-efficacy is believed to influence how people feel, think and behave. For 
instance, in terms of feelings, individuals with lower self-efficacy may harbor more 
pessimistic feelings about their personal accomplishments and, in turn, experience 
psychopathologies such as depression and anxiety. In terms of cognition, individuals with 
a strong sense of self-efficacy may experience better cognitive processes that facilitate a 
sense of confidence that may enhance their motivations. Lastly, in terms of behavior, 
individuals with high sense of self-efficacy may feel more confident about performing a 
challenging task (Bandura, 1982a; Schwarzer & Reinhard, 1995).  
 
Self-Efficacy & Health 
A large body of literature demonstrates that self-efficacy is related to successful 
health outcomes. Many studies have examined the role of self-efficacy in self-
management skills and chronic disease outcomes. In a study conducted by Clark and 
Dodge, self-efficacy beliefs concerning an individual’s ability to exercise and diet were 
associated with improved self-reports of health status, and a decrease in visits to 
providers (Clark & Dodge, 1999). Similarly, improved health outcomes have been found 
in studies exploring diabetes management (Aalto & Uutela, 1997). Furthermore, in 
studies of relapse in smoking cessation, self-efficacy has been used to assess situations in 
which individuals experience most difficulty in avoiding smoking. In a study, participants 
judged their ability to remain abstinent in ‘high risk’ situations, and self-efficacy 
assessments were used to predict outcomes following a behavioral treatment program. 
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 When smoking rates were examined at follow-up, self-efficacy was significantly 
associated with smoking status at 3-months (r=-.50), 6-months (r=-.36) and 1-yr follow 
up (r=-.15). Overall, 79% of participants with high self-efficacy scores had congruent 
changes in smoking behavior; in other words, higher self efficacy was associated with 
reduced smoking, and lower self-efficacy was associated with increase in smoking 
(Colletti, Supnick, & Payne, 1985). In addition, self-efficacy research has been conducted 
in other health-related areas including eating disorders, pain management, cardiac 
rehabilitation, negotiation of safer sex practices, exercise and physical activity 
motivation, and nutrition and weight control (O'Leary, 1985; Schwarzer, 1992; 
Schwarzer & Reinhard, 1995) .   
 
Self-Efficacy Measurement 
It is evident that capturing self-efficacy as it relates to health outcomes is of high 
clinical value. Several instruments to gauge self-efficacy have emerged in the last two 
decades. Researchers have developed tools to assess self-efficacy as it relates to disease 
management such as chronic obstructive pulmonary disease (COPD), asthma, arthritis, 
diabetes and heart failure (Frei, Svarin, Steurer-Stey, & Puhan, 2009). Some examples 
include self-efficacy scales to explore compliance in utilization of hearing aids (West & 
Smith, 2007), to explore the moderating effects of self-efficacy on empowerment of 
abused women (May & Limandri, 2004), and to assess self-efficacy of recovery demands 
faced by domestic violence victims (Benight, Ironson, & Durham, 1999).  Measuring 
self-efficacy requires the development of an instrument that is specific to a situation, 
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 disease, population or characteristic (Bandura, 2006). Hence, the plethora of self-efficacy 
measures in the literature.  
 
Dimensions of Self-Efficacy 
The construct of self-efficacy can be measured in three dimensions: magnitude, 
strength, and generality. “Magnitude” refers to expected performance attainments and 
ordering of tasks by level of difficulty. For example, a person with low-magnitude 
expectations feels able to perform simpler tasks, whereas a person with high-magnitude 
expectations feels more capable to perform more difficult tasks. “Strength” has to do with 
the confidence in attaining each expected level (i.e. a person’s judgment of how certain 
he/she is to perform a specific task). For example, a person with weak expectations of 
mastery of a specific task is less confident in performing such task, contrary to a person 
with strong expectations. “Generality” refers to the extent to which a person’s efficacy 
expectations about a task or behavior may not generalize to other situations or 
experiences. (Bandura, 1977, 1982a, 1982b; O'Leary, 1985). To exemplify generality, a 
person may be confident to exercise under supervised conditions (e.g. at a health club), 
but their self-efficacy may not have generality outside these supervised conditions (e.g. at 
home). As discussed above, each of these dimensions has important implications on 
performance. In terms of measurement, each of these self-efficacy dimensions can be 
measured by different procedures. For example, individuals may rank performance 
activities by various levels of difficulty (magnitude), they can rate the activities that they 
believe can perform based on their confidence (strength), or they can gauge their 
capability to perform a certain behavior in other situations (generality).  
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Sources of Efficacy Information 
 There are four major sources of self-efficacy expectations: performance 
accomplishments, vicarious experience, verbal persuasion, and physiological feedback. 
First, performance accomplishments refer to learning through personal experience, and 
are considered the most powerful source of efficacy. A task or behavior that is learned 
through personal experience is achieved by overcoming difficulty or fears, and refining 
and mastering a behavior or task. Such mastery of behavior results in an increase in self-
efficacy and acquisition of coping mechanisms used to deal with obstacles required to 
master the behavior at hand (Bandura, 1986).  
 The second source of efficacy is vicarious experience, which refers to learning 
through observation of other people, referred as ‘models’. Models illustrate the desired 
behavior. It is important that the model is perceived by the observer to have overcome 
difficulty through determination and hard work, so that the model affects the observer 
positively. In addition, positive efficacy effects are believed to be stronger if the model 
and the observer share common characteristics (Bandura, 1986).    
 The third source of efficacy is verbal persuasion. Here, individuals are verbally 
encouraged to perform a behavior and persevere in the efforts to change or maintain it. 
Verbal persuasion is a widely used method in the context of health education. Adoption 
of health promoting-behaviors and refraining from health-impairing behaviors proves to 
be a challenging task for many individuals, especially in terms of disease management 
(Bandura, 1986). Research under this domain explores the moderating and mediating 
effects of self-beliefs as predictors of behavior (Schwarzer & Reinhard, 1995). 
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  Lastly, physiological feedback is the fourth source of efficacy expectations. 
Bandura asserted that high physiological arousal can potentially impair performance 
(Bandura, 1986), which is in line with studies that examined the relationship between 
perceived self-efficacy and depression, anxiety,  feelings of hopelessness and low self-
esteem (Locke & Latham, 1990) .       
Although there are various sources of efficacy expectations, each of them do not 
directly and solely affect perceived self-efficacy. Individuals gather and process 
information from all of these sources, and the sources act as mediators of the impact of 
self-efficacy on behavior. It is important to understand that efficacy is influenced by 
many other factors, and that often times, other psychological concepts may influence self-
efficacy expectations. Some of these concepts include health locus of control, self-
esteem, anxiety, depression, and coping mechanisms. It is important to note, that 
although these constructs influence self-efficacy, marked distinctions exists amongst 
these psychological constructs and the construct of self efficacy. Strecher and colleagues 
(1986) reviewed and explained these concepts and their distinction as follows. First, locus 
of control is an expectation that one’s health is controlled by external forces beyond one’s 
control, whereas self-efficacy has to do with one’s perceived capability to perform a 
desired behavior.  Next, self-esteem refers to self-worth, whereas self-efficacy is an 
evaluation of one’s capability to perform under specific situations. Then, anxiety and 
depression deal with feelings about inefficacy to deal with events or get certain outcomes, 
whereas self-efficacy assesses one’s performance of a desired behavior, not whether one 
can perform that behavior without feelings of anxiety or depression. Lastly, coping is 
considered a process of assessment of one’s possibilities in face of adversity, whereas 
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 self-efficacy is an assessment of one’s capabilities to perform a desired behavior in face 
of adversity (Strecher, DeVellis, Becker, & Rosenstock, 1986).   
Self efficacy as described above is a seminal construct in models of health 
behavior and a critical factor in the assessment of health behavior. There has been an 
increased interest in the measurement of this construct in the field of behavioral health 
research as it is helpful to identify barriers to care, to detect differences among diverse 
groups, and most importantly, to aid in the prediction of health behavior. Many 
instruments have been developed to explore the role of self-efficacy as it relates to 
chronic disease prevention and control, including in the field of oncology.  
 
Self-Efficacy & Oncology 
For many years the field of behavioral oncology has tried to understand the 
intricate psychosocial factors related to cancer. Cancer is a prevalent chronic disease and 
there are many behavioral and social factors that influence cancer health outcomes. 
Cancer prevention is among the Healthy People 2020 Objectives. Specifically, increasing 
the proportion of adults that are counseled about the current cancer prevention guidelines, 
and increasing the number of adults who receive colorectal and breast cancer screenings 
(C-16 to C-18; (Healthy People 2020, 2011). Because of these objectives and other public 
health goals, behavioral scientists have focused on investigating pathways to behavioral 
change in oncological services. One important thesis is of the extent of an individual’s 
perceived capability to perform behaviors related to cancer screenings. As discussed 
earlier, self-efficacy has been shown to positively impact health outcomes, thus 
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 mechanisms related to increase cancer screening behaviors, including self-efficacy, are of 
great importance in the field of behavioral oncology.  
Many researchers have measured self-efficacy related to performing cancer-
related skills through single-item or very short assessments in a variety of health 
behaviors. Bastani and colleagues assessed confidence in performing breast self-
examinations with a single item in a study conducted in California (Bastani, Marcus, & 
Hollatz-Brown, 1991); Similarly, Allen and colleagues (1998) assessed, with 2-single 
items, the level of confidence of participants in discussing mammography screening with 
their health care provider and in maintaining their scheduled mammograms (Allen, 
Sorensen, Stoddard, Colditz, & Peterson, 1998). Another study assessed efficacy to 
perform breast self-examinations, efficacy to obtain a clinical breast exam, and efficacy 
to obtain a mammography with 3 single items (Kurtz, Given, Given, & Kurtz, 1993). 
Boehm and colleagues measured confidence in performing prostate-cancer-related tasks 
among African American males with a 4-item questionnaire, and results showed that 
participants’ self-efficacy scores improved (t= -6.14; p=<.001) after attending an 
educational program on prostate cancer (Boehm et al., 1995). Others have assessed 
participants’ ability to perform a fecal occult blood test (FOBT) with a single item scored 
in a 4-point-likert scale, and results showed that one of the factors related to adherence to 
FOB testing was self-efficacy; other factors included demographic characteristics and 
having concerns about the disease (Myers et al., 1994). 
There are very few validated cancer-related self-efficacy scales. One of the few 
studies on cancer screening behavior related to self-efficacy was conducted by Wehrwein 
and Eddy (1993). The study was conducted with a small sample of women taking part in 
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 a clinical breast exam and mammography screening program at a Women’s Center 
affiliated with a community hospital. Participants completed a 22-item self-efficacy 
questionnaire, developed by Coppel (1980), and other questionnaires about health-
promoting behaviors, lifestyles and locus of control. Researchers found that self-efficacy 
was a significant predictor of health promoting behaviors (r= .32; p<.05), and the scale 
had a very good internal reliability score of .91, but no other psychometric information 
was reported on the scale (Wehrwein & Eddy, 1993). Other studies have assessed self-
efficacy related to adjustment and promotion of health with cancer patient populations, 
and results showed positive correlations between self-efficacy and quality of life, and 
negative correlations with psychological symptoms (Lev & Owen, 1996). Then, more 
recently, the validation of two self-efficacy scales were published in the literature. First a 
10-item scale to assess self-efficacy of mammography screening was developed in 2005 
(Champion, Skinner, & Menon, 2005). Psychometric examinations revealed that the 
measure had good internal consistency (α=.87) and moderately acceptable test-retest 
reliability (r=.52, p <.001). Furthermore, the study findings indicate that higher self-
efficacy scores increased the likelihood that participants would receive a mammogram, 
specifically, for every point increment in the self-efficacy scale, a woman was 1.09 times 
more likely to get a mammogram (OR=1.09, 99% CI, 1.06 to 1.22); physicians’ 
recommendation and income were also related to higher likelihood of receiving 
mammograms (OR=1.77; 99% CI, 1.13 to 2.76, and OR=2.07; 99% CI, 1.51 to 2.84, 
respectively). A second relatively recent study developed an instrument to examine 
cervical cancer screening self-efficacy among low-income Mexican American women. 
The final scale was comprised of 8 items with high internal consistency (α=.95). Content 
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 validity was evaluated for content relevancy, and the instrument was translated into 
Spanish using “universal broadcast Spanish” (Fernandez et al., 2009). Study results 
showed that women with higher self-efficacy were more likely to have had a recent Pap 
test than those with lower self-efficacy scores. Even though the psychometric properties 
and overall characteristics of this instrument look promising for a clinical application, it 
is hard to generalize their findings to other populations, since the study’s target 
population was women of Mexican origin living in southern Texas and California.  
 The evidence presented above exemplifies how perceived self-efficacy helps 
investigators understand how psychological pathways contribute to behavior modification 
when it comes to cancer-related behaviors, including cancer screenings.  These 
mechanisms should be further explored and their clinical and practical value should be 
emphasized amongst practitioners who can counsel their patients by providing them 
feedback that would enhance patients’ knowledge and enhance skills that would enable 
patients to become more efficacious about getting the health care they need. This is also   
a potential area of study for intervention programs aiming to promote early detection and 
prevention of cancer. 
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THEORETICAL FRAMEWORK 
 
This study used the social cognitive theory as a theoretical framework. The social 
cognitive theory, developed by Albert Bandura in 1962, was derived from previous 
explorations of human behavior; Bandura further added to these explorations the concept 
of social learning. From this theoretical perspective, human behavior is the product of the 
interaction of social, environmental, and personal factors. The product of this interaction 
involves the influence of people’s thoughts and actions; human beliefs and cognitive 
competencies which are the products of social influences and structures within 
environments; and, behaviors that determine aspects of the environments. According to 
this theory, cognition plays a critical role in an individual’s capability to make sense of 
reality, self-regulate, assimilate information, and most importantly, perform a behavior.  
This theory helps explain the pathways by which human behavior is influenced by 
environmental outcomes, and by an individual’s cognitive processes and interpretation of 
outcomes. According to Bandura (1986), “a theory that denies that thoughts can regulate 
actions does not lend itself readily to the explanation of complex human behaviors.” 
(Bandura, 1986) Social cognitive theory poses a view of human capacity in which 
individuals are actively involved in their own development and can make things happen 
through their own actions. In other words, “what people think, believe, and feel affects 
how they behave” (Bandura, 1986).  
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 Hence, the beliefs that individuals hold about themselves are fundamental in the 
exercise of control and personal capacity. These beliefs are also important in collective 
capacity, which makes this theory applicable to human adaptation and change in 
collectivistic societies, as it is largely the target population of this study.    
Social cognitive theory posits that socio economic factors, such as economic 
status, educational attainment, and familial structures, may influence self-efficacy beliefs 
indirectly. Furthermore, knowledge and skills influence individual’s behavior, but only to 
a certain level; often times not enough to achieve the desired behavioral change. As 
Bandura (1997) states, “people’s levels of motivation, affective state, and actions are 
based more on what they believe than what is objectively true” (Bandura, 1997). Thus, 
behavior often can be better predicted by people’s beliefs on what they can achieve than 
what they actually know or are capable of accomplishing.   
PERSON BEHAVIOR OUTCOME 
Efficacy  
Expectations
Outcome  
Expectations
 
 
Figure 1. Theoretical model 
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AIMS 
 
There is a dearth of validated measures to assess the perceived ability to obtain the 
recommended care after an abnormal cancer screening. To the authors’ knowledge, no 
validated measure assessing self-efficacy following a cancer abnormality under a number 
of barriers to care has been published.  
For this reason, this study aims to:  
1. Evaluate content validity of the measure using a panel of experts.  
2. Conduct an Exploratory Factor analysis to explore the instrument’s internal 
structure. 
3. Assess the internal consistency reliability of the measure.  
4. Examine convergent and discriminant validity. 
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HYPOTHESES 
 
On the basis of earlier research documented in the literature, the following hypotheses 
were formulated: 
1. Factor Analysis will yield at least one factor. 
 
2. The self-efficacy instrument will be found to be a reliable measure of self-efficacy 
as will be demonstrated by a Cronbach’s alpha coefficient of .70 or greater.  
 
3. The self-efficacy instrument will be positively correlated with theoretically-
related variables (convergent validity) as follows: 
a. Outcome Expectations: Positive correlation coefficients (> 0.30) will be 
found between self-efficacy scale and cancer response scales (breast and 
colorectal),  
b. Perceptions of Control: Positive correlation coefficients (>.30) will be 
found between self-efficacy scale and Personal Mastery Scale. 
 
4. The self-efficacy instrument will be weakly, negatively correlated with a 
theoretically-related variable (discriminant validity): Depression. Correlation 
coefficients (<.0) will be found between self-efficacy and depression.   
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METHODS 
Overview 
The purpose of the study was to describe the development and psychometric 
evaluation of a measure of self-efficacy for obtaining follow-up care following an 
abnormality suspicious for cancer. To do this, the study utilized a multi-step process to 
reduce the original pool of items (item refinement phase I) and obtain evidence of 
validity and reliability (item refinement phase II; see figure 2). Further details are 
explained in the sections below. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Overview of study 
  
 
 
 
DEVELOPMENT OF THE SELF-EFFICACY MEASURE 
 
The self-efficacy measure utilized in this study was developed by investigators of 
a patient navigator research project (PNRP) of the Moffitt Cancer Center site. The PNRP 
is a federally-funded research project aimed at reducing cancer health disparities by 
eliminating barriers to access to care through the provision of culturally-appropriate 
services of a Patient Navigator (Freund et al., 2008; Wells et al., 2008). Patient navigators 
were lay individuals from the community who were trained to provide services and health 
resources to patients, and navigate them through the health care system in a timely 
manner (Wells et al., 2011). The PNRP-Moffitt was part of a nation-wide, multi-site 
program funded by the National Cancer Institute through the Patient Navigator Outreach 
and Chronic Disease Prevention Act in 2005.  
Guided by Bandura’s social cognitive theory, and with medically underserved 
populations in mind, a team of PNRP-Moffitt investigators developed a self-efficacy 
instrument to assess participant’s confidence in their ability to acquire needed follow-up 
care under various circumstances after having an abnormal cancer screening. Several 
items were generated to reflect multiple steps associated with obtaining follow up care, 
including potential instrumental, logistic and belief barriers that may play a role in 
preventing help-seeking behaviors. The original instrument was comprised of 51 items, 
most of which start with “I can…”; some items ask about the participant’s perceived 
ability in getting follow-up care even if encountered with barriers, and other items ask 
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 about the participant’s perceived ability to overcome barriers proactively or by seeking 
someone else’s help. The response scale of this instrument consists of a 5-point Likert-
like scale (Strongly agree, Agree, Neutral, Disagree, and Strongly disagree; see appendix 
I for English version and appendix J for Spanish version). An initial draft of the measure 
was tested with a small sample of community participants using cognitive interviews. 
The cognitive interviews helped identify semantic and grammatical issues, language 
idiosyncrasies and overall participants’ comprehension of the items. Items were refined 
based on feedback obtained from these cognitive interviews. 
Subsequently, the instrument was pilot tested with a sample of baseline 
participants (n=106) from the PNRP-Moffitt project, and these data was utilized to 
answer the research questions of this project. Pilot test data collection is described in the 
following sections.   
 
Pilot Test Study Design & Sample 
Using a cross-sectional study design, the PNRP project collected psychosocial 
data to assess study aims at baseline (following an abnormality suspicious for cancer), at 
resolution (after receiving follow-up care that may or may not result in a diagnosis of 
cancer), and during treatment (for those patients diagnosed with cancer). Self-efficacy 
data were only collected at one administration point: following the discovery of a 
symptom or screening abnormality for breast or colorectal cancer (i.e. baseline). One-
hundred and six participants participated in the pilot test of the self-efficacy measure. The 
sample composition was as follows: 78% completed the instrument in Spanish (n=83) 
and 22% completed the instrument in English (n=23). The large majority of respondents 
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 were enrolled for breast abnormalities (n=92), and 13% for colorectal abnormalities 
(n=14). 
Study Setting & Population: The pilot study was conducted at Moffitt Cancer 
Center, located in Tampa, FL. The PNRP participants were recruited from federally 
qualified health centers and hospitals within four counties of Central West Florida: 
Hillsborough, Pinellas, Pasco, and Manatee.  The population of Central West Florida is 
highly diverse.  
First, Hillsborough has an estimated adult population of 772,255 people, and 
approximately 15% of its population is foreign born. It is estimated that 12% of its 
population is over 65 years. Furthermore, it is estimated that 9.6% of families in this 
county live below the poverty levels (US Census Bureau, 2006-2008). As to diversity, 
while Caucasian race is the most prominent race of all, there are several minority 
communities in the county, African-Americans and Hispanics being the largest (16% and 
22%, respectively).  
Pasco county’s population is estimated at 417,028 people, 7% of which are 
foreign born. Languages other than English are spoken in 10.3% of the households. 
77.6% of it population are high school graduates. Twenty-one percent of its population is 
over the age of 65 (US Census Bureau, 2006-2008). Although the majority of the 
population is Caucasian (90.3%), this county has a large farm working population.  
Pinellas County is the second smallest county in Florida. Nevertheless, it is 
considered the most densely populated in the state (Pinellas County Government, 2006). 
Its population was estimated at 910,260 people in 2008. A small segment (9.5%) of its 
population is foreign born, and in 12% of its households, languages other than English 
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 are spoken. Pinellas has a substantial percentage of African Americans (10%), about 7% 
of Hispanics, and approximately 3% of Asians. Twenty percent of people in this county 
are over the age of 65 (US Census Bureau, 2006-2008).  
Manatee County’s estimated population in 2008 was 315,766 people. Eight 
percent of its population is foreign born, and languages other than English are spoken in 
12.3% of its households. Twenty-two percent of the population is 65 years or older (US 
Census Bureau, 2006-2008). 
 
Pilot Data Collection 
Participants: Participants were referred to the PNRP by health care providers of 
the 12 participating community health clinics. Patients presenting with an abnormal 
screening test or physical finding for breast or colorectal cancer were eligible to 
participate if they received care at the participating health center and were 18 years of age 
or older. Patients newly diagnosed with breast or colorectal cancer were eligible to 
participate if they had not undergone cancer treatment. In addition, patients diagnosed 
with cancer within five years of the referral, or patients with previous history of other 
cancers, except non-melanoma skin cancer, were ineligible to participate in the PNRP 
study. Once enrolled in the main program, all participants were eligible to participate in a 
survey to assess psychosocial outcomes of patient navigation. Participants were contacted 
at baseline. 
Measures & Materials: Participant demographic information was collected in 
person from study participants using a demographics questionnaire with items regarding 
participants’ race, ethnicity, education, marital status, nationality, native language, 
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 language preference, housing, employment and insurance status. The demographic 
questionnaire was professionally translated into Spanish (see Appendix A for English 
version and Appendix B for Spanish version-demographics). In addition, participants 
were administered a battery of 14 instruments including: 
 
 A Cancer Response Efficacy Scale (see Appendices C & D), which measures 
outcome expectations related to a) breast and b) colorectal cancer. The scale is 
comprised by 4-5 items, and it is answered in a 5-point Likert-like scale (Strongly 
Agree to Strongly Disagree). Outcome expectations is conceptually defined as 
judgments of the consequences that a) having a mammogram or b) having a 
colorectal cancer screening will produce. In the study, lower scores reflect better 
(+) outcome expectations, possible scores for the 5-item breast response efficacy 
scale are 1-25, and scores for the 4-item colorectal cancer response efficacy scale 
are 1-20. 
 
 The Personal Mastery Scale (Pearlin & Schooler, 1978), measures perceptions of 
control, which is conceptually defined as the extent to which a person perceives 
circumstances as being under his/her own control. This scale consists of 7 items 
and it is answered in a 5-point Likert scale (Strongly Agree to Strongly Disagree). 
The scale has previously shown moderate test-retest reliability (.44) and construct 
validity (Pearlin, Menaghan, Morton, & Mullan, 1981); Scoring for this scale 
ranges from 1 to 35. In the study, some items in the scale were reverse coded, so 
lower scores reflect higher perceptions of control. 
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  The Patient Health Questionnaire (PHQ) depression module #9, which is a brief 
9-item instrument to assess depression according to DSM-IV criteria, answered 
from “Not at all” to “Nearly Every Day.” The PHQ-9 is a reliable and valid 
measure of depression severity (α=.89) (Kroenke, Spitzer, & Williams, 2001); In 
this study, higher scores reflect more depression symptoms, and scores can range 
from 1 up to 36 (see appendix G for English version and appendix H for Spanish 
version). 
 
 A self-efficacy instrument, consisting of 51 items in a 5-point Likert-like scale 
(Strongly agree, Agree, Neutral, Disagree, and Strongly disagree). In this study, 
lower scores in the scale mean that participants have high confidence in their 
ability to obtain follow-up care after having a cancer abnormality. Scores can 
range from 1 to 255 (see Appendix I for English version and Appendix J for 
Spanish version).  
 
Procedures: Upon enrollment, i.e. after subjects had agreed to participate and 
signed an informed consent to participate in the PNRP, participants were contacted over 
the phone to take part in a 60-minute in-person interview including the administration of 
all the other tools. The interviews were conducted by three research assistants (RAs), in 
English or Spanish. Survey participants were administered a battery of 14 instruments 
during the interviews at baseline. For the majority of participants, instruments were read 
to them in their totality, and response cards, in English or Spanish, were used to assist 
participants with remembering the response scales. The instruments that were not readily 
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 available in Spanish were translated by a certified professional translator and 
backtranslated by a member of the PNRP staff.   
 
Data Management 
 Hard copies of survey data were stored in locked cabinets at Moffitt Cancer 
Center. Participants’ identity and confidentiality were protected by assigning a participant 
ID that was a combination of numbers created by the PNRP. Electronic data were stored 
in databases that were located in secured network folders restricted to research personnel 
only. The databases were backed up daily, and data accuracy was confirmed with testing 
a small sample of entries.  
 All research personnel received training on research involving human subjects 
and HIPPA regulations.     
Survey data were entered in a password-secured Access database, and 10% of 
data were checked randomly for accuracy of data entry.  
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DATA EXAMINATION 
 
The first step of this study, as shown in figure 2, was to conduct a preliminary 
examination of the data collected in the pilot test phase.  Data were examined using 
descriptive statistics generated using the Statistical Package for the Social Sciences, 
version 20 (SPSS, 2011).  
First, a descriptive table of the sample, containing frequencies, variance, etc., was 
generated using all 51 items in the scale. Variables with high non-completion rates (i.e. 
variables containing more than 5% of missing data) were discarded. Variability of 
responses was examined by looking at measures of data dispersion, and items with low 
variability (i.e. items with standard deviation of less than .75) were eliminated. Low 
dispersion indicates that responses were not spread out across response options 1-5.  Non-
completion rates and low variability of responses may be indicative of items that are hard 
to answer or not relevant to participants. This data reduction strategy was performed to 
facilitate other steps in the development of the instrument. Overall, the goal of this 
project was to identify the best possible items to include in a self-efficacy scale for 
obtaining follow-up care after a cancer abnormality.  
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CONTENT VALIDITY ASSESSMENT 
 
 In order to further examine psychometrics of the self-efficacy measure, the study 
conducted content validity assessments using a panel of experts identified purposively 
based on their knowledge and expertise regarding self-efficacy.  
The goal of assessing content validity is to determine whether items in an 
instrument are in fact relevant to the construct of interest, and also to assess if all areas of 
interest under this construct are covered by the instrument (Brod, Tesler, & Christensen, 
2009).  There is a debate in the literature as to whether or not content validity should be 
used in instrument psychometric assessment because some investigators believe that 
“content validity deals with inferences about test construction; construct validity involves 
inferences about test scores. Since by definition all validity is the accuracy of inferences 
about test scores…content validity is not validity at all” as cited in (Beckstead, 2009), p. 
1276). Others propose that inter-rater agreement is the best procedure for calculating 
content validity, as it represents the extent to which raters make exact judgments about 
items. Despite this, multiple researchers utilize content validity assessments in their scale 
constructions as it provides information about the item clarity, representativeness and 
relevance to the construct, and it also provides valuable feedback for improving the 
measure by evaluating each item in the scale (Chung, Wong, & Griffiths, 2007; May & 
Limandri, 2004; Rubio, Berg-Weger, Tebb, Lee, & Rauch, 2003; Schilling et al., 2007; 
Zimmaro Bliss, Dhamani, Savik, & Kirk, 2003). Based on the review of the literature and 
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 having considered the divergent points of view regarding content validity, this project 
conducted an examination of the content validity because it provided a valuable 
assessment of the items’ content and relevance to a construct (e.g. self-efficacy). In 
addition to rating relevancy, reviewers were asked to assess item’s clarity, redundancy, 
and they were asked to provide recommendations related to refinement of wording and 
content domain of items. 
Previous studies on content validity have revealed that the number of experts may 
vary between 2 and 20. Many of the studies recommend that at least 3 experts review 
measures of the size of the measure in this study (Polit & Beck, 2006). Recommendations 
for forming a panel of experts include: selecting experts that are well versed in the 
subject of interest and who have instrument development expertise (Davis, 1992; 
Schilling, et al., 2007). 
 
Content Validity Assessment Methods 
Sample: Snowball sampling was utilized to identify content validity reviewers. 
According to inclusion criteria reviewers had to: a) be professionals with varying levels 
of health care experience, b) have theoretical and practical understanding of the 
conceptual framework underlying the instrument i.e. self-efficacy, c) have instrument 
development expertise, and d) be able to read, write and speak fluent English and/or 
Spanish language. Any individual involved in the development of the original instrument 
was excluded and could not serve as a content validity reviewer.  
Participants: A sample of reviewers (n=12) were identified based on the criteria 
described above. After reviewers were identified, each of them received an email 
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 soliciting their assistance and participation in this project (see Appendix K). No monetary 
incentives were provided to the reviewers; however, reviewers were offered a copy of the 
final instrument as an incentive to participate. Seven content validity assessments were 
conducted in English, and five assessments were conducted in Spanish language (see 
results for further details).  
Materials: Experts were asked to rate each instrument item using a content 
validity rating form in either English or Spanish, depending on their language preference 
(see Appendix L). The rating form explained in detail how to complete the assessment, 
provided an overview of the instrument, described the domains to be rated (i.e. relevance, 
clarity, and redundancy), and provided a definition of the domain under assessment (i.e. 
self-efficacy). Reviewers were asked to rate each item as “Relevant” “Somewhat 
relevant” “Slightly relevant” and “Not relevant at all,” as this is a recommended method 
to assess variability of rating amongst reviewers (Polit & Beck, 2006). In addition, 
reviewers were asked to provide feedback on the items’ clarity (e.g. “item is not clear”, 
“item needs major revisions”, “item needs minor revisions”, “item is clear”). Lastly, 
reviewers were asked to provide comments for each item (e.g. related to item 
redundancy, or linguistic and cultural acceptability of items). Each of these steps aided 
decisions regarding item retention and deletion. The rating form utilized for the study is a 
modified version of the content validity rating form described in another study (Rubio, et 
al., 2003).   
Procedures: Experts were contacted by electronic, telephonic or personal 
communications. An initial invitation was mailed or emailed to potential reviewers, and 
additional reviewers were referred by other reviewers in a snowball technique. Reviewers 
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 who agreed to participate were sent a rating form, described above. Reviewers were 
asked to complete the rating form and send it back electronically or by mail. The 
assessment form was estimated to take 20 minutes to complete. Five of the assessments 
were conducted in Spanish language in order to assess the content validity of the Spanish-
language items, using the same methodology as the English-language content validity 
assessments (See Appendix L).  
Data Management: Answers were de-identified and recorded on a score sheet and 
then entered on a spreadsheet for record keeping. No other data from the reviewers were 
collected, and no data were linked to their names or any other personal identifier. All 
study data were stored in a password-protected computer. 
Analysis: Reviewer agreement was assessed manually using a multi-rater method 
to calculate the item-by-item content validity index as discussed in Polit & Beck (2006). 
First, ratings are examined and subsequently collapsed into dichotomous variables. Then, 
item-by-item calculations were performed by identifying the items that had relevancy (of 
relevant or somewhat relevant) ratings across all raters. Rating procedures are further 
explained in the results section. Judgments on the retention of items were evaluated upon 
receipt of all ratings. Generally, studies only retain items with scores of 80% agreement 
or higher, across raters (Davis, 1992; Selby-Harrington, Mehta, Jutsum, Riportella-
Muller, & Quade, 1994); However, based on practical knowledge and recommendations 
from committee members, this study retained items with 60% or higher agreement across 
raters. Ratings were examined independently by language (English or Spanish). Lastly, 
ratings on clarity were tallied and qualitative responses were compiled in a separate table.   
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PSYCHOMETRIC EVALUATION 
 Psychometric evaluation of newly-developed instruments is pivotal in behavioral 
measurement. Researchers have an essential need to evaluate, examine, and assess 
different behaviors; hence, a good gauging mechanism is needed. As a result, several 
systematic methods have been developed to explore the properties and characteristics of 
instruments. The following section describes the methods that were utilized to evaluate 
psychometric properties of the self-efficacy measure for obtaining cancer-related follow-
up care after an abnormality suspicious for cancer.   
Data were analyzed using Statistical Package for the Social Sciences (SPSS Inc., 
2011). Descriptive statistics were used to summarize demographic information about 
participants. Inferential statistics were conducted to assess the psychometric properties of 
the scale and to test the study hypotheses. Data cleaning measures were taken prior to the 
analysis of data.  
 
Factor Analysis 
An Exploratory Factor Analysis (EFA) was conducted to identify underlying 
factors of the instrument. An EFA is commonly utilized to a) determine a set of common 
factors influencing a construct in an instrument, b) identify a set of items that could be 
group together to form a factor, and c) gauge the strength of the relationship between a 
factor and each item that fall within it (DeCoster, 1998; Nunnaly & Bernstein, 1994). 
Costello and Osborne (2005) conducted a review of studies reporting usage of EFA in 
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 scale development, and while the majority (62.9%) of the studies utilized a 10:1 (subject 
to item) ratio, 15% of the studies reported having conducted factor analyses of 2:1 or less 
ratios. It is also important to note that their analyses of the effects of subject-to-item 
ratios on EFA’s specificity concluded that utilizing larger samples can yield more 
accurate EFA results (Costello & Osborne, 2005). 
In this study, an EFA was utilized to examine possible underlying factors within 
the SE measure that was previously developed. The initial pool of items (i=51) was 
significantly reduced, from 51 items to 13 items, after the item reduction strategies 
utilized in the previous item refinement section. Consequently, the study utilized a 
moderate subject to item ratio (8:1) to construct an EFA. 
Methods of Analysis: Maximum likelihood was the procedure chosen to fit the 
Common factor model in the EFA conducted. Frabrigar and colleagues (1999) 
recommend this fit for data that do not violate the normality assumption ( skew < 2; 
kurtosis < 7; Fabrigar, Wegener, MacCallum, & Strahan, 1999). The number of factors 
retained was determined by a visual examination of a scree plot. This graphical 
representation of eigenvalues was examined, and the number of eigenvalues that occured 
before plateau was the number of retained factors.  The study utilized an oblique rotation 
method (direct oblimim) as there were some correlations among the factors.   
 
Reliability Analysis 
 The scale reliability was assessed by calculating internal consistency reliability 
(cronbach’s alpha). Internal consistency is an assessment of the homogeneity of the items 
that comprise the scale (Ferketich, 1991). Linkages between the items exist, and the 
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 assessment of the instrument’s reliability allowed linkages between items and the latent 
construct to emerge. A scale is internally consistent if its items are highly inter-
correlated. High-item inter-correlations may suggest that the items are all measuring the 
underlying construct. Assumptions can be made that correlations between items reflect 
strong links between items in the scale and the underlying domain. In addition, item-to-
total scores reflect the impact of a given item on the entire scale, especially if the item is 
deleted. 
 
Validity Analysis 
A correlation matrix was constructed to examine the relationship between self-
efficacy and other study variables (outcome expectations, perceptions of control, and 
depression). To assess convergent and discriminant validity, patterns of inter-correlations 
between the two measures were examined. Pearson’s product moment correlation 
coefficients between theoretically-related measures should be high (convergent), while 
correlations between theoretically unrelated measures should be low (discriminant). It 
was hypothesized that outcome expectations and perceptions of control would be highly 
correlated with self-efficacy, to provide evidence of convergent validity. Whereas, low 
correlations between depression and self-efficacy would provide evidence of discriminant 
validity, as theoretically, they should differ.  
In terms of convergent validity, relationships between SE and perceptions of 
control were assessed, as there is documented evidence of a positive association between 
these two constructs (Bandura, 1977; Grecas, 1989). Although these two constructs are 
distinct, such as self-efficacy expectations have to do with the person’s ability to perform 
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 a certain behavior, and perceptions of control, aka personal mastery, is the extent to 
which a person believes that an outcome is controllable (Bandura, 1977). These two 
constructs can influence behavioral outcomes by taking into consideration personal 
capabilities (e.g. a person’s confidence in getting screened) and controllable outcomes 
(e.g. beliefs of personal control over one’s health screening behaviors).   
Similarly, outcome expectations are “judgments of the likely consequences a 
behavior will produce” (p. 438), in other words, outcomes expectations are an 
individual’s beliefs of whether a behavior will lead to a certain (positive or negative) 
outcome (O'Leary, 1985). Outcome expectations are also closely related to perceived 
self-efficacy, and both have shown predictive values of intention to engage in a behavior. 
Although outcome expectations and self-efficacy are two different constructs, Bandura 
proposed an inter-relational nature of these two constructs due to the influence of 
outcomes expectations on beliefs of self-efficacy. For instance, if an individual lacks 
confidence to perform a behavior, balancing benefits and consequences of such behavior 
will not be powerful enough to perform the behavior. Likewise, feelings of perceived 
inefficacy can nullify any positive outcome expectations about such behavior (Schwarzer 
& Reinhard, 1995).  
To assess discriminant validity, the relationship between depression 
symptomatology and self-efficacy will be examined. Theoretically, these two constructs 
are distinct, as self-efficacy differs from depression in that latter is a mental disorder that 
disrupts a person’s social functioning and interferes with well-being, whereas self-
efficacy has to do with a person’s perceived ability to perform a desired behavior. 
Depression is accompanied by feelings of hopelessness, negativism and low sense of 
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personal agency. It was hypothesized that these two measures would correlate negatively 
and have a low correlation coefficient; meaning that a person with higher depression 
scores (as measured by the PHQ-09) might exhibit lower Self-efficacy scores.  In order to 
gather evidence of discriminant validity, the strength, rather than the direction of the 
association was examined. Depression and self-efficacy might correlate negatively 
because of their theoretical association; however, in order in terms of validity, their weak 
association provides evidence of the distinction between these two constructs.  
Furthermore, gathering sufficient evidence of theoretically-related constructs and 
theoretically-unrelated constructs between measures is one way of calculating construct 
validity (Nunnaly & Bernstein, 1994; Rubio, et al., 2003). 
 
  
 
 
 
RESULTS 
Data Examination Results 
The first step of this study was to examine the composition and quality of 
variables contained in the self-efficacy measure. Descriptive statistics were utilized to 
generate a snapshot of the 51 self-efficacy items. Variability and completion rates were 
examined as a data reduction strategy. Items were eliminated based on two criteria: a) 
low variability rates (sd < 0.75), and b) low completion rates (more than 5% of missing 
data at the variable level). Table 1 provides a summary of variables deleted and variables 
retained for additional analyses.  
As seen in table 1, a total of 38 variables were eliminated based on these criteria. 
The majority of these variables were found to have low variability. Low variability 
indicates that responses were not spread out across response options (i.e. strongly agree 
to strongly disagree). These items may have been difficult to understand or simply not 
relevant to participants in the sample. For this reason, it is important to eliminate these 
items in early stages of data analysis. A smaller number of variables, 7 out of 38, were 
eliminated due to a significant percentage of missing data (>5%). Lack of responses also 
may be indicative of problematic items which participants may have found hard to 
answer or not relevant.  
 The remaining items (13), as summarized in table 2, were found to meet the 
inclusion criteria. Thus, these items were retained. 
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Table 1. Deleted items based on variability and completion rate criteria (items=38) 
Item 
Standard 
deviation
(< .75) 
Missing 
data (> 
5%) 
Reason for deletion 
 
bse1 .749 Low variability 
bse4 .607 Low variability 
bse5 .651 39 (36.7%) Missing data 
bse6 .506 Low variability 
bse7 .539 Low variability 
bse8 .537 Low variability 
bse9 .705 11 (10.3%) Missing data 
bse10 .730 Low variability 
bse11 .675 Low variability 
bse12 .489 Low variability 
bse14 .710 Low variability 
bse15 .697 Low variability 
bse17 .680 38(35.8%) Missing data 
bse18 .736 9 (8%) Missing data 
bse19 .639 Low variability 
bse20 .571 Low variability 
bse21 .583 Low variability 
bse22 .553 7 (6%) Low variability/ missing data 
bse23 .533 Low variability 
bse24 .533 Low variability 
bse25 .472 Low variability 
bse26 .676 Low variability 
bse28 .601 44 (41.5%) Missing data 
bse29 .576 Low variability 
bse30 .472 Low variability 
bse31 .628 Low variability 
bse32 .697 Low variability 
bse33 .628 Low variability 
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Table1. (Continued) 
 
 
Item 
Standard 
deviation
(< .75) 
Missing 
data (> 
5%) 
Reason for deletion 
bse34 .487 Low variability 
bse35 .625 43 (40.5%) Missing data 
bse36 .518 Low variability 
bse37 .667 Low variability 
bse38 .549 Low variability 
bse39 .626 Low variability 
bse40 .520 Low variability 
bse43 .692 Low variability 
bse48 .720 Low variability 
bse50 .564  Low variability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Items retained after data examination analysis (i=13) 
 
 
Item 
Standard 
deviation 
 
Missing 
data  
(> 5%) 
bse2 1.195  
bse3 .782  
bse13 .779  
bse16 .782  
bse27 .789  
bse41 .763  
bse42 .763  
bse44 1.045  
bse45 .950  
bse46 1.054  
bse47 .880  
bse49 .770  
bse51 .859  
 
 
  
Content Validity Analysis Results 
 The next step of the development of this instrument was to assess content validity 
(CV) to determine content relevance of the items, thus assessing the extent to which the 
instrument was indeed a measure of self-efficacy for obtaining follow up care following 
an abnormality suspicious for cancer. Item clarity was also examined in this step.  
  Sample Composition: A total of fourteen investigators were contacted and asked 
to participate in the content validity assessment of this instrument. Seven researchers 
were contacted to review English-language items, and the other seven were contacted to 
review Spanish-language items. All seven English-speaking individuals who were asked 
to provide CV ratings agreed to take part and completed the rating form. These English-
language reviewers were a post-doctoral trainee (n=1) and professors (n=6) at academic 
and non-profit health institutions in the states of Florida, Georgia, and Maryland. Five out 
of seven Spanish-speaking researchers who were asked to take part in the study agreed to 
review and rate the items. Their professional training ranged from a doctoral student 
(n=1) to post-doctoral trainees (n=2) to academic professors (n=2) at educational 
institutions in Florida, California, and Texas. One person declined participation due to 
time constraints, and one person did not respond.  
 Interpretation of Content Validity ratings: The study calculated a content validity 
index at the item level and at a scale level, as described by Polit 2006. The item content 
validity index (I-CVI) is an index of agreement among reviewers and it was calculated 
by, first, dichotomizing ratings (of quite relevant and highly relevant as “relevant -1-”, 
and ratings of not relevant and somewhat relevant into “not relevant -0-”), and then 
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 calculating the average of “relevant -1-“ ratings across all reviewers. For example, in 
Table 3, six out of seven reviewers rated item2 as relevant. Thus, the I-CVI equals 0.86, 
whereas item3 was rated as relevant by all 7 reviewers, hence its I-CVI equal 1.00. The 
mean I-CVI was calculated by summing all I-CVIs and dividing by the number of items.  
The Scale Content Validity Index (S-CVI) is the proportion of items in the scale 
given a rating of “relevant -1-” by all reviewers. For instance, the last column in table 3, 
labeled “rated relevant by all,” indicates that eight out of thirteen items were rated as 
relevant by all experts. Therefore, the S-CVI/UA equals 0.62 (i.e. 8/13). The Mean 
Expert Proportion, which is an average of the proportion of items rated as relevant across 
reviewers, is also reported in the table. To calculate this, first, individual reviewers’ 
ratings have to be averaged (e.g. reviewer1 rated relevant 12 out of 13 items, average 
ratings for reviewer1 =.92; reviewer2 rated 11 out of 13 items as relevant, average ratings 
for reviewer2 = .85, and so forth), then reviewers’ average ratings are combined and 
divided by the number of reviewers in the sample (a second average calculation). The 
mean expert proportion always equals the mean I-CVI (0.95), as seen in table 3. 
There are important distinctions between I-CVI and S-CVI, as described above, 
and Polit (2006) recommends to not only report both index scores, but also to provide an 
explanation on how these indexes were generated.  
Content Validity Results:  For the English-language items (i=13) the I-CVIs 
ranged from 0.86 to 1.00 (mean I-CVI = 0.92; as seen in table 3), and for Spanish-
language items I-CVI ratings ranged from 0.60 to 1.00 (mean I-CVI = 0.92; as seen in 
table 4). The English-language instrument had a S-CVI value of 0.62, whereas the 
Spanish-language instrument had a S-CVI value of 0.69.  
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Content validity assessments were utilized as a second step in the instrument 
development process. Retention criterion was set to I-CVI = 0.60, which is more liberal 
than the acceptable standard of .80. As summarized in tables 3 and 4, all English and 
Spanish items met the retention criteria. To explore relationships among these variables, a 
correlation matrix was generated (see table 5). Table 5 indicate that there are some small-
to-moderate correlations between the items, except for items 42 and 27, which are highly 
correlated (r=.723). 
 
 
 Table 3. Content Validity Ratings - English-language Items 
 
 
 Content Validity Reviewers 
Item # Reviewer1 
Reviewer
2 
Reviewer
3 
Reviewer
4 
Reviewer
5 
Reviewer
6 
Reviewer
7 
Number in 
Agreement 
 
Item 
CVI 
Rated 
relevant 
by All 
2 1 0 1 1 1 1 1   6 0.86
3 1 1 1 1 1 1 1
13 0 1 1 1 1 1 1
16 1 1 1 1 1 1 1
27 1 1 1 1 1 1 1
41 1 1 1 1 1 1 1
42 1 1 1 1 1 1 1
44 1 0 1 1 1 1 1
45 1 1 1 1 1 1 1
46 1 1 1 1 1 1 1
47 1 1 1 0 1 1 1
51 1 1 1 1 1 1 1
   7 1.00 1
   6 0.86
   7 1.00 1
   7 1.00 1
   7 1.00 1
   7 1.00 1
   6 0.86
   7 1.00 1
   7 1.00 1
   6 0.86
49 1 1 1 1 na 1 1 6 0.86
   7 1.00 1
 0.92 0.85 1.00 0.92 0.92 1.00 1.00 8
   MEAN I-CVI †= 0.95
   S-CVI/UA ††= 0.62
   Mean expert proportion 0.95
 
†  I-CVI, item-level content validity index. 
†† S-CVI/UA, Scale-level content validity index, universal agreement calculation method. 
(Polit & Talano Beck, 2006) 
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 Table 4. Content Validity Ratings - Spanish-language Items 
 
 Content Validity Reviewers 
Item # Reviewer 1 
Reviewer 
2 
Reviewer 
3 
Reviewer 
4 
Reviewer 
5 
Number in 
Agreement 
 
Item 
CVI 
Rated relevant 
by All 
2 1 1 1 1 1 5 1.00 1 
3 1 1 1 1 1 5 1.00 1 
13 1 1 1 1 0 4 0.80  
16 1 1 1 1 1 5 1.00 1 
27 1 1 1 1 1 5 1.00 1 
41 1 1 1 1 1 5 1.00 1 
42 1 1 1 1 1 5 1.00 1 
44 1 1 1 1 0 4 0.80  
45 1 1 1 1 1 5 1.00 1 
46 1 1 1 1 1 5 1.00 1 
47 1 0 1 1 1 4 0.80  
49 1 0 1 1 0 3 0.60  
51 1 1 1 1 1 5 1.00 1 
 1.00 0.85 1.00 1.00 0.77   9 
      MEAN I-CVI † = 0.92  
      S-CVI/UA †† = 0.69  
     Mean expert proportion 0.92  
†  I-CVI, item-level content validity index. 
†† S-CVI/UA, Scale-level content validity index, universal agreement calculation method. 
(Polit & Talano Beck, 2006)
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Table 5. Inter-item correlations 
 
 
 bse2 
1
bse3 bse13 bse16 bse27 bse41 bse42 bse44 bse45 bse46 bse47 bse49 bse51 
bse2              
bse3 .292** 
 
 
 
 
 
 
 
 
 
 
 
1            
bse13 .315** .133 1           
bse16 .215* .281** .363** 1          
bse27 .155 .560** .210* .337** 1         
bse41 .063 .295** .396** .160 .421** 1        
bse42 .242* .488** .251** .301** .723** .290** 1       
bse44 .087 .161 .291** .333** .271** .326** .254** 1      
bse45 .218* .314** .469** .500** .263** .304** .397** .352** 1     
bse46 .188 .085 .343** .269** .288** .344** .308** .694** .450** 1    
bse47 .273** .120 .480** .315** .246* .317** .360** .391** .457** .405** 1   
bse49 .205* .357** .074 .418** .481** .157 .468** .153 .358** .255** .332** 1  
bse51 .196* .316** .469** .209* .302** .493** .390** .410** .398** .343** .539** .099 1 
  
Item Clarity Results: Reviewers were also asked to rate each item’s clarity 
(Appendix L).  Table 6 and table 7 summarize clarity ratings by the number of reviewers 
who rated each item as item is clear, item needs minor revisions to be clear, item needs 
major revisions to be clear, or item is not clear. As seen in Table 6, none of the English-
language items was rated as not clear. At least three, and as high as six, reviewers agreed 
that an item was clear. Agreement in terms of revisions ranged from 1 to 4; in other 
words, some items had suggestions for revisions by all 4 reviewers, whereas for other 
items, only one reviewer suggested revisions for an item.  
Clarity ratings for the Spanish-language instrument are markedly different from 
the English ratings. Unlike the English-language items, three items were rated as not 
clear by three independent reviewers (although data in table 7 is not displayed by 
reviewer).   Also, a larger number of revisions were suggested by reviewers for the 
Spanish-language items. 
Qualitative data gathered from reviewers, from the comment section, can be 
found in Appendix N. Suggestions for revisions ranged from wording modifications to 
cultural nuances in language to recommendations for item deletion based on redundancy 
or repetition. These recommendations were especially helpful for the final stages of the 
development of this instrument, as some items were slightly modified based on 
reviewers’ comments (see later results and discussion section). These comments were 
also considered in later stages, when making decisions to eliminate certain items in the 
scale as discussed later.  
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 Table 6. Clarity Ratings by reviewers (n=7) for English-language instrument 
 
  
Item # 
Rated as 
clear  
(n) 
Need minor 
revisions  
(n) 
Need major 
revisions 
 (n) 
Rated as not 
clear  
(n) 
Suggested 
revisions  
(n) 
  
2 3 2 1 0 3 
3 5 2 0 0 2 
13 4 1 2 0 3 
16 3 4 0 0 4 
27 4 2 1 0 3 
41 5 1 1 0 2 
42 5 1 1 0 2 
44 6 1 0 0 1 
45 5 2 0 0 2 
46 6 1 0 0 1 
47 3 3 1 0 4 
49 3 3 0 0 3 
51 5 2 0 0 2 
  
 
 
 
 
 
 
 
 
*Each column indicate the number of reviewers who rated item as clear (column 1), item needs 
minor revisions (column2), item needs major revisions (column3), or item is not clear (column 4). 
Last column indicates the total number of reviewers who suggested revisions to that item (out of 
seven reviewers). 
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*Each column indicate the number of reviewers who rated item as clear (column 1), item needs 
minor revisions (column2), item needs major revisions (column3), or item is not clear (column 
4). Last column indicates the total number of reviewers who suggested revisions to that item (out 
of five reviewers). 
 
Item # 
Rated as 
clear  
(n) 
Need minor 
revisions  
(n) 
Need major 
revisions 
 (n) 
Rated as not 
clear  
(n) 
Suggested 
revisions 
(n) 
2 1 1 2 0 3 
3 1 1 2 0 3 
13 0 1 2 1 3 
16 1 2 1 0 3 
27 1 2 1 0 3 
41 3 0 1 0 1 
42 5 0 0 0 0 
44 0 2 1 1 3 
45 1 1 2 1 3 
46 2 1 1 0 2 
47 0 3 1 0 4 
49 1 2 1 0 3 
51 5 0 0 0 0 
Table 7. Clarity Ratings by reviewers (n=5) for Spanish-language instrument 
 
 
 
 
 
 
 
 
 
 
 
 
  
Factor Analysis Results 
Thirteen variables were analyzed in an exploratory factor analysis using a 
Maximum Likelihood method and an direct oblimin (oblique) rotation. The visual 
examination of the scree plot suggested a 4-factor solution (see figure 3), where as 
eigenvalues (>1) suggested that only three factors be retained. Each variable that loaded 
onto a factor (>0.3) were examined, and based on item characteristics, factors were 
interpreted to reflect barriers encountered by participants when trying to obtain 
recommended follow-up care. The factors that emerged are as follows: Factor 1 (costs of 
care), Factor 2 (transportation), Factor 3 (structural barriers related to health care 
system), and Factor 4 (communication). A factor structure matrix and eigenvalues can be 
found in tables 8 and 9, respectively. In table 8, it is important to note that item 49 
loading in factor 3 showed a negative coefficient (-.123); all other loadings seem fine. 
Table 10 displays factor loadings (i.e. coefficients) and percent of variance accounted for 
as a result of the factor analysis performed. Most items seemed to load strongly, and there 
were only a few items that cross-loaded onto other factors (e.g. 41 [I can get to a health 
care appointment even if it is far away], 13 [I can talk to my health care provider even if 
I have difficulty understanding him or he], and 49 [I can get follow-up health care even if 
I usually use natural remedies to treat disease]). In fact, item 49 cross-loaded across 
three factors (2, 3, and 4), yet it did not belong conceptually to any of these factors. For 
this reason, item 49 was eliminated and another factor analysis was performed.  
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 Figure 3. Scree plot for 4-factor solution 
 
Table 8. Factor Structure Matrix for four-factor solution, including item 49 
 
 
 
 
 
 
 
 
 
 
 
Factors 
Variable Factor 1: 
Cost 
Factor 2: 
Transportation 
Factor 3: 
Structural 
Factor 4: 
Communication 
bse46 .993 .232 .254 .421 
bse44 .701 .243 .356 .360 
bse27 .333 .935 .154 .383 
bse42 .352 .748 .237 .518 
bse3 .095 .638 .170 .369 
bse49 .222 .549 -.123 .547 
bse51 .411 .336 .807 .422 
bse41 .386 .415 .511 .266 
bse45 .449 .321 .306 .733 
bse16 .268 .381 .093 .652 
bse47 .428 .277 .494 .590 
bse13 .371 .212 .516 .517 
bse2 .196 .225 .153 .392 
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 Table 9. Initial Eigenvalues and total variance explained for by four-factor solution 
 
 
 
 
 
 
Initial Eigenvalues 
Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadings 
Factor Total 
% of 
Variance 
Cumulative 
% Total 
% of 
Variance 
Cumulative 
% Total 
1 4.829 37.148 37.148 2.513 19.329 19.329 2.720 
2 1.665 12.804 49.952 2.661 20.467 39.796 2.960 
3 1.151 8.852 58.804 1.221 9.394 49.190 1.865 
4 1.104 8.494 67.298 .730 5.615 54.805 3.136 
5 .816 6.279 73.577     
6 .732 5.631 79.209     
7 .597 4.596 83.804     
8 .520 3.999 87.803     
9 .504 3.879 91.682     
10 .335 2.573 94.255     
11 .307 2.358 96.614     
12 .237 1.820 98.433     
13 .204 1.567 100.000     
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 Table 10. Self-efficacy measure items and pattern matrix coefficients for 4-factor solution  
 
  Factors 
Item description Variable
Factor 1:
Cost 
Factor 2: 
Transportation 
Factor 3:
Structural
Factor 4: 
Communication 
I can get medicines even if I have trouble 
paying for them. bse44 .633 .034 .111 .044 
I can get follow-up health care even if I have 
trouble paying for it. bse46 1.033 -.042 -.119 .031 
I can get transportation to health care 
appointments even if I cannot drive a car.  bse3 -.156 .606 .095 .127 
I can get transportation to health care 
appointments even if there is no bus. bse27 .130 .956 -.016 -.115 
I can find people who can help me get to my 
clinic appointments. bse42 .089 .636 .058 .167 
I can get to a health care appointment even if it 
is far away. bse41 .180 .337 .414 -.079 
I can get follow-up health care even if I get 
frustrated with things that go wrong at the 
clinic.  
bse47 .118 -.024 .332 .462 
I can get to a health care appointment that is in 
a place I have never been to. bse51 .051 .140 .729 .140 
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Table 10. (continued) 
 
Item description Variable
Factor 1: 
Cost 
Factor 2: 
Transportation 
Factor 3:
Structural
Factor 4: 
Communication 
I can talk to my health care provider even if I have 
difficulty understanding him or her. bse13 .073 -.062 .391 .411 
I can talk to my health care provider even if he or 
she does not speak my language. bse2 .017 .049 .046 .349 
I can fill out forms at the clinic even if I have trouble 
writing. bse16 .007 .101 -.093 .627 
I can get follow-up health care even if I do not 
understand the health problem. bse45 .146 -.044 .082 .670 
I can get follow-up health care even if I usually use 
natural remedies to treat disease. bse49 .048 .385 -.317 .431 
% of variance explained by factor  19.32 20.46 9.39 5.61 
Coefficients greater than 0.30 are bold. Extraction Method: Maximum Likelihood.  Rotation Method: Direct Oblimin. 
 The visual examination of the scree plot, for the second factor analysis, suggested 
a 3-factor solution. The pattern matrix (as seen in table 11) revealed two factors which 
were consistent with the previous 4-factor solution: Factor1 (Costs) and Factor 2 
(Transportation). However, the third factor was a combination of items which previously 
loaded onto the Structural and Communication factors in the initial 4-factor solution. 
Item 49 was retained to preserve a meaningful structure of the instrument because the 4-
factor-solution is easier to interpret in terms of factors. Items loading onto those 4-factors 
seem to belong better conceptually than those items loading onto a 3-factor solution.       
 
 
Table 11. Pattern matrix for 3-factor solution, not including item 49 
 
 
Factors 
Variable Factor 1: 
 
Factor 2: 
 
Factor 3: 
 
bse46 1.022 -.018 -.035 
bse44 .603 .028 .148 
bse27 .136 .955 -.147 
bse42 .090 .669 .130 
bse3 -.145 .642 .097 
Bse13 -.021 -.115 .757 
bse51 .055 -.063 .700 
bse45 -.024 .061 .670 
Bse16 .145 .019 .573 
Bse2 .034 .176 .385 
bse41 -.001 .071 .341 
 
 
 
 
 
 
 
 
Coefficients >.3 are bold 
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Reliability Analysis Results 
The next step was to assess the internal consistency reliability of the scale and 
subscales. As a total self-efficacy scale, the instrument was comprised of 13 items with 4 
sub-scales and a single item (49), which was retained not to compromise the factor 
structure. However, item 49 was not included in the calculation of the scale total or in any 
of the subscales onto which it previously loaded (i.e. Transportation, Structural and 
Communication subscales).  
The study hypothesized that the instrument would have a Cronbach’s alpha 
greater than 0.70 (Hypothesis 2). Internal Consistency for the scale total was high 
(Cronbach’s α = 0.84). This alpha score not only supports the hypothesis, but also 
indicates that the items contained in the scale are homogeneous. As seen in Table 12, all 
item-to total correlations are above 0.3, which is considered appropriate, and alpha-if-
item-deleted ratings do not seem to suggest strong recommendations for item deletions, 
except for item 2 (whose Alpha would increase to 0.85 if deleted). Nonetheless, this item 
was retained because there was no other indication in previous item refinement stages 
that suggested otherwise. The average item mean was 2.27 and the average inter-item 
correlation was 0.32, ranging from 0.62 to .72. The total scale scores ranged from 12 to 
42, out of a possible 60, and the mean was 27.27 (SD= 6.51), indicating that participants 
felt somewhat efficacious about obtaining the recommended follow up care.  
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Table 12. Total scale item statistics (12 items) 
Variable 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Mean Std. Deviation 
bse44 .529 .831 2.69 1.045 
bse46 .560 .828 2.74 1.054 
bse3 .429 .837 2.08 .782 
bse27 .531 .831 2.08 .789 
bse42 .578 .828 2.07 .759 
bse41 .487 .833 2.07 .759 
bse47 .582 .826 2.27 .876 
bse51 .595 .825 2.20 .855 
bse2 .314 .853 2.71 1.195 
bse13 .553 .829 2.06 .779 
bse16 .473 .834 2.03 .774 
bse45 .607 .824 2.30 .945 
     
 
Item level analysis of subscales: The first subscale, Costs, is comprised of 2 items, and it 
shows good internal consistency reliability (α = 0.81). The next subscale, Transportation, 
is comprised of 3 items and it also shows good internal consistency reliability (α = 0.81). 
Similarly, the structural subscale, has 3 items, and also shows good internal consistency 
(α = 0.71). The last subscale, Communication¸is comprised of 4 items, and shows the 
lowest Cronbach’s alpha of all subscales (α = 0.64). In fact, item-total statistics suggested 
that if item 2 is deleted, Cronbach’s alpha for this subscale would have increased to 0.70. 
Corrected item-total correlations, Cronbach’s-alpha-if-item-deleted scores, means and 
standard deviations are displayed in table 13.  
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Table 13. Item statistics by subscales 
 
Subscale Variable 
Inter-Item 
Correlation 
r 
Cronbach’s 
if item 
deleted 
Mean Std. Deviation 
bse44 .69 . 2.69 1.045 
Costs 
bse46 .69 . 2.74 1.054 
bse3 .56 .83 2.08 .782 
bse27 .74 .65 2.08 .789 Transportation 
bse42 .68 .71 2.07 .759 
bse41 .46 .70 2.07 .759 
bse47 .50 .65 2.27 .876 Structural 
bse51 .63 .47 2.20 .855 
bse2 .31 .70 2.71 1.195 
bse13 .51 .53 2.06 .779 
bse16 .46 .56 2.03 .774 
Communication 
bse45 .50 .52 2.30 .945 
 
 
Subscale item-total correlations ranged between 0.31 and .74. Not surprisingly, 
the smallest item-total correlation was from item 2. Therefore, additional reliability 
analyses were conducted, item 2 was removed from the Communication subscale and the 
subscale reliability was re-calculated. As a result, internal consistency reliability for this 
subscale increased from 0.64 to 0.81. The new item-total statistics showed item-total 
correlations higher than 0.30 (0.4, 0.5, and 0.5, for items 13, 16, and 45, respectively), 
and deleting any additional items from this subscale would not have increased its internal 
consistency.  
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Following the elimination of item 2, internal consistency reliability for the scale 
total was also recalculated. Cronbach’s did not increase significantly (α [12 items] = 0.84, 
α (11 items) = 0.85). New item-to total correlations are displayed in table 14, and all are 
above 0.3, and alpha-if-item-deleted ratings do not seem to suggest strong 
recommendations for item deletions.  
 
Table 14. Total Scale item statistics (11 items) 
 
Variable 
Corrected 
Item-Total 
Correlation
Cronbach's 
Alpha if 
Item Deleted
Mean Std. Deviation 
bse44 .559 .840 2.69 1.045 
bse46 .569 .839 2.74 1.054 
bse3 .402 .850 2.08 .782 
bse27 .544 .840 2.08 .789 
bse42 .575 .838 2.07 .759 
bse41 .517 .842 2.07 .759 
bse47 .572 .838 2.27 .876 
bse51 .605 .835 2.20 .855 
bse13 .532 .841 2.06 .779 
bse16 .467 .846 2.03 .774 
bse45 .613 .834 2.30 .945 
                   α = 0.85  
 
Since eliminating item 2 from the self-efficacy scale did not seem to have a great 
impact on the overall reliability scores of the scale, the scale was kept intact. Additional 
reasons were taken into consideration when making this decision, which are later 
discussed in later sections. Hence, the final self-efficacy instrument contains 12 items. 
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 Validity Analyses Results 
 The relationship between the self-efficacy instrument and other theoretically 
related instruments were examined in order to obtain evidence of two types of validity: 
convergent and discriminant validity. Pearson Product-moment correlation coefficients 
were calculated to assess these relationships.  
 Convergent validity: The study hypothesized that 1) self-efficacy was positively 
correlated with Outcomes Expectations (OE; hypothesis 3a), and 2) self-efficacy was 
positively correlated with Perceptions of Control (PC; hypothesis 3b). Because outcome 
expectations differ by cancer type (breast vs colorectal) independent correlation analyses 
were conducted for each group. Eighty-three participants with breast cancer 
abnormalities and 12 participants with colorectal cancer abnormalities completed the 
outcome expectations questionnaire; eleven participants did not complete these 
instruments. Tables 16 and 17, display correlations by cancer type, including only 
participants who completed all the questionnaires (n=83 for breast, and n=12 for 
colorectal). Table 15 displays correlations between for all participants (breast and 
colorectal) for self-efficacy, perceptions of control and depression.  
Hypothesis 3a. Results of the correlation analyses showed a small, positive 
correlation between SE and OE-Breast (r= .13, p > .05; table 16), and a moderate 
negative correlation between SE and OE-Colorectal (r= -.29, p >.05; table 17). Evidence 
partially supports the hypothesis, perhaps due to sample size.  
Hypothesis 4. There is a significant, small positive correlation between SE and PC 
(r= .19, p = .05; table 15). Moreover, PC and depression are significantly, negatively 
correlated, as theoretically expected (r= -.364, p<.001), 
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 Table 15. Correlations and descriptive statistics for self-efficacy, perceptions of control 
and self-efficacy scales (breast and colorectal combined). 
 
Scale Mean SD SE PC Depression 
Self-Efficacy (SE) 27.27 6.51 1   
Perceptions of Control 
(PC) 
16.53 4.40 .191* 1  
Depression 29.47 6.07 -.024 -.364** 1 
      
 N=106. * denotes correlation is significant at the 0.05 level ** denotes correlation 
significant at the 0.01 level (2-tailed).  
 
 
 
 
Table 16. Correlations and descriptive statistics for all scales (breast only) 
 
Scale Mean SD SE OE-B PC Depression 
Self-Efficacy (SE) 27.67 6.29 1    
Outcome 
Expectations (OE-B)  13.02 1.91 .136 1 
  
Perceptions of 
Control (PC) 
16.44 4.31 .160 .049 1  
Depression 30.21 5.51 .018 -.075 -.352** 1 
       
N=83. ** denotes correlation significant at the 0.01 level (2-tailed).  
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 Table 17. Correlations and descriptive statistics for all scales (colorectal only) 
 
Scale Mean SD SE OE-C PC Depression
Self-Efficacy 
(SE) 27.58 5.36 1    
Outcome 
Expectations 
(OE-C) – 
Colorectal  
9.83 2.08 -.292 1 
  
Perceptions of 
Control (PC) 
18.50 4.58 .253 .029 1  
Depression 26.41 7.89 .234 .477 .431 1 
       
   N=12. 
 
  
 
Discriminant validity: The study hypothesized that there would be a weak 
negative association between self-efficacy and depression (hypothesis 3b). Results of the 
correlation analyses (in table 15) showed a very weak negative correlation (r = -.02), thus 
supporting the hypothesis.  
Construct Validity: Results of these correlation analyses provided evidence of 
convergent and discriminant validity. Although the associations between SE and OE were 
not supported in participants with colorectal abnormalities (n=12), there is evidence of 
convergent validity from SE and PC correlations. Hypotheses are supported and there is 
evidence of construct validity.  
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 An additional correlation matrix was generated to assess the relationships between 
self-efficacy subscales, depression and perceptions of control. Results (table 18) show 
that perceptions of control scores are significantly correlated with two self-efficacy 
subscales (transportation r = .30, p < .01; and structural r= .21, p <.01) at a moderate 
magnitude. In addition, there is a small negative correlation between depression and three 
self-efficacy subscales (transportation r= -.10, p > .05; communication r= -.01, p > .05; 
and structural r= -.04, p >.05). Interestingly, depression scores and self-efficacy–costs 
are positively correlated.   
 As explained above, separate analyses were conducted to examine associations 
between outcome expectations and the self-efficacy subscales. Correlations displayed in 
Table 19 utilized data from 83 participants who had breast abnormalities suspicious for 
cancer. Results indicate that there are weak correlations between outcomes expectations 
and the following self-efficacy subscales: Costs (r= .009, p >.05), transportation (r= .03, 
p >.05) and communication (r= .09, p >.05).Outcome expectations and the structural 
subscale are significantly moderately correlated (r= .27, p <.05).  
 
 
 
 
 
 
 
 
 
 Table 18. Correlation matrix assessing relationships between perceptions of control and depression by self-efficacy 
subscales (breast and colorectal; n=106) 
 
 PC Depression Costs Transportation Structural Communication 
PC 1      
Depression -.364** 1     
Costs .014 .071 1    
Transportation .301** -.106 .290** 1   
Structural .216* -.046 .505** .445** 1  
Communication .036 -.010 .394** .446** .450** 1 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Table 19. Correlation matrix assessing relationships between perceptions of control, depression, and outcome 
expectations by self-efficacy subscales (breast only; n=83) 
 
 
 
 
  
PC Depression Costs Transportation Structural Communication Outcome 
Expectations
PC 1       
Depression -.352** 1      
Costs .041 .001 1     
Transportation .260* -.045 .287** 1    
Structural .146 -.010 .541** .375** 1   
Communication .021 .081 .396** .402** .416** 1  
Outcome 
expectations .049 -.075 .009 .030 .270
* .097 1 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
 
  
 
 
 
DISCUSSION 
 
The purpose of the study was to examine the psychometric properties of a self-
efficacy measure developed to assess patients’ perceived capability to obtain 
recommended follow-up care after receiving an abnormality suspicious for cancer. A 
multi-step approach was utilized to assess psychometric properties of the instrument.  
Content validity assessments conducted in Phase I of the study provided 
information about the items’ semantic and grammatical composition, and relevance to 
self-efficacy. Reviewers provided feedback on ways to improve item’s clarity and 
recommendations to simplify items by providing low-literacy-appropriate alternatives. 
Appendix M lists revisions recommended by reviewers. For example, in items 44 and 46 
the word “trouble” was substituted for “difficulty” because a few of the English 
reviewers disliked the wording. In Spanish however, the item did not have to be modified 
as it already reflected such wording. Items 13 and 2 were reworded to be more action-
specific, as according to Bandura, self-efficacy is a context-specific construct; for that 
reason, transforming these items to a more action-oriented composition may be more 
appropriate. Consequently, item 13 “I can talk to my health care provider even if I have 
difficulty understanding him or her” was modified to “I can ask questions to my health 
care provider if I have difficulty understanding him or her;” and item 2 “I can talk to my 
health care provider even if he or she does not speak my language” was modified to “I 
can request an interpreter if my health care provider does not speak my language” 
(additional comments on this item rewording are provided below). Other items such as 
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 items 27 “I can get transportation to health care appointments even if there is no bus” 
and 41 “I can get to a health care appointment even if it is far away” were reworded to 
more generalizable terms for populations living outside of Florida who may use other 
means of transportation or may reside in pedestrian cities.  
Lastly, reviewers’ comments were taken into consideration in the decision-
making process for item deletion/retention. For example, during the EFA, item-total 
statistics suggested that item 2 “I can talk to my health care provider even if he or she 
does not speak my language” be removed from the scale. However, following the 
removal of this item, psychometric composition of the scale did not improve 
significantly. When reviewer’s comments were re-revisited, they suggested that this item 
had poor wording, and that the meaning of the item may have been clouded by a minor 
language idiosyncrasy. Nonetheless, the item could be salvaged by clarifying a way in 
which a person would go about communicating with a health care provider in face of a 
language obstacle (i.e. using an interpreter). For this recommendation and the one 
described before, item 2 was reworded to “I can request an interpreter if my health care 
provider does not speak my language.” Reviewers’ comments on item 49 “I can get 
follow-up health care even if I usually use natural remedies to treat disease” were also 
re-examined after this item cross-loaded onto 3 other factors. Reviewers thought that this 
item lacked clarity and precision; it was also suggested that access to care would not be 
compromised if a person uses natural remedies to treat disease. The latter comment may 
or may not be true. Nevertheless, most of the reviewers did not like this item and one 
said: “I’m not sure if you really need this,” which may be interpreted as if the item is not 
relevant or that it does not go with the other items in the scale.      
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 One of the aims of the study was to determine if the instrument had any 
underlying subscales. It was hypothesized that the scale would have at least one main 
factor. However, the EFA revealed a 4-factor solution, which is reflective of types of 
barriers to care such as costs of care, transportation barriers, structural barriers related to 
the health care system, and communication barriers. These logistical, structural, and 
interpersonal barriers to care have been well documented in the literature as contributing 
factors of health disparities. Barriers to medical care can have an impact in morbidity and 
mortality rates (Borrayo & Guarnaccia, 2000; Brown, et al., 2011; Carpenter & Colwell, 
1995; Wolff, et al., 2003); therefore, having an instrument that can gauge perceived 
capability for obtaining care in the presence of a number of barriers can substantially aid 
health care providers in the development and implementation of health care programs that 
are aimed at eliminating barriers to care, such as the implementation of patient navigators 
who can help attenuate these barriers.    
 Other study hypotheses stated that the instrument would be found to be a valid 
and reliable measure of self-efficacy. As discussed in the result section, most hypotheses 
were supported. Self-efficacy and perceptions of control were significantly positively 
correlated (r=.19, p<.01); in other words, data suggested that patients who perceive 
barriers to care under their control may be more self-efficacious about getting 
recommended cancer care. Data also suggested that high levels of perceptions of control 
are related to having less depression symptomatology (r= -.36, p<.01). Similarly, feeling 
more efficacious may be related to feeling less depressed (r=-.02, p>.01). 
When self-efficacy subscales were reviewed independently to examine their 
relation to depression, transportation, communication and structural subscales were 
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 found to negatively correlate with depression as well, except for the costs subscale. The 
costs subscale was positively correlated with depression (r= .07, p>.01). Nonetheless, 
none of these relationships was statistically significant.  
An interestingly significant correlation was found between breast outcome 
expectations and the structural subscale (r= .27, p<.01). In other words, participants who 
had more positive expectations about having a breast diagnostic exam (e.g. a 
mammogram, a biopsy, etc) felt more efficacious about getting the recommended exam 
in face of barriers such as distance of a health care facility, familiarity with the facility, or 
things that may go wrong there. This finding has some clinical value since the 
relationship between these two variables (as seen in figure 1) can impact health 
outcomes. In other words, seeing a greater benefit for getting a recommended diagnostic 
test, may be related to better feelings of efficacy in face of barriers, such as those in the 
structural subscale, hence enhancing the chance of getting the recommended test. 
Though, this is only an assertion with little statistical support.      
Outcome expectations related to colorectal cancer screening were not correlated 
with any other measure (as seen in table 16). As discussed previously, this may be due to 
low sample size (n=12); however, instability of this scores may also be attributed to 
issues with the instruments utilized to assess outcome expectations. These instruments 
have not been validated and the item wording may have been ambiguous for some 
participants. Furthermore, the content of this items were closely related to the 
participant’s knowledge of breast or colorectal cancer screening. It is uncertain whether 
the scores may be a reflection of the lack of participant’s knowledge on cancer screenings 
67 
 
 68 
 
or expected outcomes from getting screened. Therefore, these results should be 
interpreted cautiously.  
 Information obtained in the study is vital in scale construction, as it is imperative 
that researchers use valid and reliable instruments to assess behaviors. As described, a 
sound self-efficacy measure can aid investigators and clinicians, who serve populations 
similar to the study’s target population, in understanding barriers that might impact 
cancer care and how individuals perceive their capacity to circumvent and overcome 
them. The implications for practice are extensive. 
 
 
  
 
 
 
 
IMPLICATIONS FOR PUBLIC HEALTH PRACTICE 
 
There are several implications for public health field in practice, education, and 
research. Unfortunately, individuals with limited financial resources and access to care 
are disproportionately affected by the burden of cancer.  This study can potentially help 
public health professionals understand the patient’s perceived barriers to care after cancer 
screenings and feelings of efficacy to acquire needed care. Studies that have examined 
adherence to screening behaviors indicate that efficacy is indeed an important mediating 
factor to obtain cancer screenings related to breast (Champion, et al., 2005; Wehrwein & 
Eddy, 1993) and colorectal health (Blalock, DeVellis, Afifi, & Sandler, 1990; DeVellis, 
Blalock, & Sandler, 1990; Hoogewerf, Hislop, Morrison, Burns, & Sizto, 1990; Vernon, 
Myers, & Tilley, 1997). It is vital that researchers and health professionals be aware of 
mediating variables to screening behaviors so that barriers to care can be eliminated and 
educational programs that increase participation can be implemented for breast and 
colorectal cancer. Identifying which barriers are most impactful can also aid in the 
provision of better services, or in the implementations of patient navigators who can help 
patients get the recommended care they need. This study developed a valid and reliable 
instrument to measure self-efficacy for obtaining follow-up care following an 
abnormality suspicious for cancer.  
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STUDY LIMITATIONS 
 
This study has some limitations related to its design and methodology. To begin 
with, the use of non-probability sampling techniques limits the generalizability of its 
results. The nature of a cross-sectional study design precludes the assessment of causal 
relationships among the examined variables. To further examine the relationship between 
self-efficacy and other variables, a longitudinal study may be necessary. Next, some data 
collection procedures such as the use of self-reported data and in-person interviews may 
create subject and interviewer biases.  
Although the results of this study may not be extrapolated to other populations, 
the author asserts that the results may be true to populations with similar characteristics to 
this study’s sample. Although the cross-sectional design of this study poses a limitation, 
this study may also provide a representative sample of the minority and medically 
underserved population of 5 counties in Central West Florida.   
A significant limitation to this study was the sample size. Because of a small 
sample size and uneven distribution of groups (by language or cancer type) some 
analyses could not be performed. Additionally, conducting an exploratory factor analysis 
with such a small subject-to-item ratio may have consequences that can threaten the 
accuracy of the factors. Nevertheless, EFA examination can provide valuable data on the 
composition of the instrument, and can yield possible factors within the scale.  
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Psychometric studies that are conducted with participants from different cultural 
backgrounds are recommended to examine cross-cultural validity because bias can cause 
score differences across groups, and invalidate inferences drawn from these scores. 
Although this type of validity was not assessed in the project because of low sample size, 
issues related to cross-cultural item bias (item translation and complex wording of items) 
were addressed by revising some items based on feedback provided by content validity 
reviewers, who commented on these very same issues. Furthermore, exploring possible 
cross-cultural differences in the theoretical definition of the construct of self-efficacy 
goes beyond the scope of this project, and it is an area to explore in future studies.  
 
 
In hindsight: 
 The content validity rating form response choices were a little ambiguous, as 
somewhat relevant and slightly relevant can be interpreted as the same response. As to 
the clarity response scale, providing a response option labeled as “item is not clear” is not 
ideal when raters can rate items as “need minor/major revisions.” Providing a “need to 
revise” option can also signify that the item is not clear, and as it needs revisions as a 
result. A response option labeled as “item is not clear at all” would have been more 
appropriate.   
 
 
  
 
 
FUTURE DIRECTIONS 
 
The study gathered evidence of two types of validity: construct validity (by 
convergent and discriminant validity), and content validity. More research is needed to 
explore other types of validity, including predictive validity. Estimating the degree to 
which the measure may predict receipt of follow-up care would be a powerful 
characteristic to add to its psychometric properties. Many may argue that beliefs about 
one’s capability to perform a behavior may not be powerful enough to achieve a 
behavioral outcome. Yet, based on the theoretical basis of social cognitive theory, 
cognition and behavior are intricately related, and thoughts of efficacy can be a powerful 
predictor of behavior.  
After conducting this study, it is imperative to test the revised self-efficacy scale 
and reassess its performance once again. As in many social disciplines measures are 
constantly reassessed. It would be beneficial to test the revised instrument with larger 
samples, more diverse populations, and even different types of cancer.   
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APPENDIX A: 
 
ENGLISH DEMOGRAPHIC QUESTIONNAIRE 
 
Now I am going to ask you some questions about yourself and your 
background. 
 
1. What is your marital status? 
1. Single/Never married  
2. Married  
3. Divorced/separated  
4. Widowed 
5. Living with a same gender partner 
 
 
2. Gender 
0. Female 
1. Male 
 
3. What is the highest grade or year of education that you have completed?  
_________ 
 
4. Do you identify yourself as Hispanic or Latino/a? 
  0. No 
  1. Yes 
 
5. What is your race (read answer choices)?  
1. White       
2. Black/African American   
3. Asian      
4. Native Hawaiian/Other Pacific Islander 
5. Native American/Alaskan Native 
6. Other____________________________________ 
7. Choose not to answer 
8. Unsure/does not know 
(if patient is confused by this question, ask alternative race question) 
 
6. Where were you born?_________________________________(country) 
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7.  What is your native language?____________________________________ 
 
8.  What is your primary language? 
  1. English 
  2. Spanish 
  3. Haitian Creole 
  4. Vietnamese 
  5. Portuguese Creole 
  6. Albanian 
  7. Cambodian 
  8. Russian 
  9. Somali 
  10. Other (__________________________________) 
 
 
9. How many people (adults and children) live with you? _____________ 
10. How many dependents live with you?_____________ 
 
11. What is your housing status (read answer choices, but not words in 
parentheses)? 
  1. Renting (apartment, home, condo, mobile home) 
  2. Own (home, condo, mobile home) 
  3. Staying with family or friends 
  4. Other (__________________________________) 
 
12. How long have you lived at your current home? 
____________ _______________ 
Years   Months 
 
13. Are you currently working outside the home for pay? 
  0. No current employment 
  1. Part-time employment 
  2. Full-time employment 
 
14. What is your occupation?_______________________________ 
 
15.  Do you have a primary care provider, like a doctor or clinic that you go to 
most of the time?  A primary care provider is a physician, nurse practitioner, or 
medical clinic that you go to when you are sick or need a check-up. 
0. No 
1. Yes 
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16.  What is the name of your primary care provider? 
 
________________________________________________________ 
 
 
17.  Is your primary care provider a doctor, physician’s assistant, or nurse 
practitioner? 
  1. Doctor (internist, ob/gyn, family practitioner) 
  2. Physician’s assistant 
  3. Nurse practitioner 
  4. Other 
  5. Does not know 
 
18.  Patient navigation is when a trained person helps or guides you to get the 
health care or treatment you need. This help may include arranging transportation, 
providing information you need, or helping to get financial support.  Have you 
ever been navigated? 
  0. No 
1. Yes (list date and health condition navigated _________________) 
 
19. What is your annual household income? 
0. Zero 
1. $1 to $9,999 
2. $10,000 to $19,999 
3. $20,000 to $29,999 
4. $30,000 to $39,999 
5. $40,000 to $49,999 
6. $50,000 to $74,999 
7. $75,000 to $99,999 
8. $100,000 or more 
 
20. What is today’s date? 
 
__ __ / __ __ / __ __ __ __ 
Month   Day      Year 
 
21.  Randomization group 
 1. Control 
 2. Navigated 
 
22. Patient ID _______________________________________ 
 
 
 
 
APPENDIX B: 
 
SPANISH DEMOGRAPHIC QUESTIONNAIRE 
 
Ahora le voy a hacer unas preguntas acerca de sus datos demográficos. 
 
1. ¿Cuál es su estado civil? 
1. Soltero(a)/jamás casado(a)  
2. Casado(a) 
3. Divorciado(a)/separado(a) 
4. Viudo(a) 
5. Unión libre con una persona de su mismo sexo 
 
2. ¿Cuál es su sexo? 
0. Femenino 
1. Masculino 
 
3.¿Cuál ha sido el grado de educación más alto que usted ha completado?_________ 
 
4. ¿Usted se identifica como Hispano(a) o Latino(a)? 
  0. No 
  1. Si 
 
5. ¿Cuál es su raza (read answer choices)?  
1. Blanca        
2. Negra/Afro-Americana   
3. Asiática      
4. Nativa de Hawai/de las Islas del Pacífico 
5. Indígena Americana/Nativa de Alaska 
6. Otra 
7. Prefiere no responder 
8.        No está seguro/ No sabe 
(if patient is confused by this question, ask alternative race question) 
  
6. ¿Dónde Nació?______________________ ____________(País) 
 
 
7.  ¿Cuál es su lengua nata?________________ ____________________ 
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8. ¿Cuál es su idioma principal? 
  1. Inglés 
  2. Español 
  3. Criollo (Haiti) 
  4. Vietnamita 
  5. Criollo portugués 
  6. Albanés 
  7. Cambodiano 
  8. Ruso 
  9. Somalí 
  10. Otro(__________________________________) 
 
 
9. ¿Cuántas personas (adultos y niños) viven con usted?_____________ 
 
10. ¿Cuántos niños que dependen de usted viven en su casa?_____________ 
 
11. ¿Cuál es su estatus de vivienda actual (read answer choices, but not words in 
parentheses)? 
  1. Renta (apartamento, casa, condominio, casa móvil) 
  2. dueño de casa, condominio, o casa móvil 
  3. Se queda en casa de familiares o amigos 
  4. Otro (__________________________________) 
 
12. ¿Cuánto tiempo ha vivido en su vivienda actual? 
____________ _______________ 
Años   Meses 
 
13. ¿Actualmente trabaja afuera de casa a sueldo? 
  0. No actualmente no trabaja 
  1. Trabaja medio tiempo 
  2. Trabaja tiempo completo 
 
14. ¿Cuál es su profesión?______________________________________ 
 
15. ¿Usted tiene un proveedor de servicios de salud primario, como por ejemplo un 
doctor o alguna clínica a la cual usted asiste la mayor parte del tiempo? Un proveedor 
de servicios de salud primario es un médico, un(a) enfermero(a), o una clínica a la 
que usted va cuando se siente enfermo(a) o necesita una revisión médica. 
0. No 
1. Si 
 
16. ¿Cómo se llama su proveedor de servicios de salud primario? 
______________________________________________ 
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17. ¿Es su proveedor de servicios de salud primario un doctor, un asistente médico, o 
un(a) enfermero(a)? 
1.     Doctor (practicante, ginecólogo, médico familiar) 
       2.      Asistente médico 
       3.      Enfermero(a) 
       4.      Otro 
       5.      No sabe 
 
18.  Navegación de Pacientes es cuando una persona entrenada le ayuda o le guía a través 
del cuidado médico o del tratamiento. Esta ayuda puede incluir hacer arreglos de 
transporte, proporcionar información, o ayudar a obtener ayuda financiera. ¿Alguna vez 
ha sido navegado? 
  0. No 
   1. Si (escriba la fecha y la condición de salud por la que se le navegó  
 
19. ¿Cuál es el ingreso anual de su casa? 
0. Cero 
1. $1 a $9,999 
2. $10,000 a $19,999 
3. $20,000 a $29,999 
4. $30,000 a $39,999 
5. $40,000 a $49,999 
6. $50,000 a $74,999 
7. $75,000 a $99,999 
8. $100,000 o más 
 
20. ¿Qué fecha es hoy? 
 
__ __ / __ __ / __ __ __ __ 
  Mes      Día         Año 
 
 
21.  Randomization Group 
 1. Control 
 2. Navigated 
 
22. Patient ID _______________________________________
 
 
 
 
APPENDIX C: 
 
ENGLISH CANCER RESPONSE EFFICACY SCALE  
 
]Breast only] The following items ask about your concerns about getting breast 
cancer.  For each question, please CIRCLE the ONE answer that best describes 
your feelings. 
 
1. When breast cancer is found early, it can be cured. 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
 
2. When a woman examines her own breasts, she can detect breast cancer at an early 
stage. 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
 
3. Having a mammogram will tell a woman whether or not she has breast cancer. 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
 
4. When a doctor examine a woman’s breasts, the exam will tell a woman whether 
she has breast cancer. 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
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5. When breast cancer screening shows that something is wrong, the chance for 
cure is great. 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagreeInstructions  
 
 
 
 
 
 
APPENDIX C (Continued) 
 
 [Colorectal only] The following items ask about your concerns about getting 
colorectal cancer.  For each question, please CIRCLE the ONE answer that best 
describes your feelings. 
 
1. When colorectal cancer is found early, it can be cured. 
 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
 
2. When colorectal polyps (growths) are found and removed, colorectal cancer can 
be prevented. 
 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
 
3. Having colorectal cancer screening will tell a person whether or not he or she has 
colorectal cancer. 
 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree 
 
4. When colorectal cancer screening shows that something is wrong, the chance for 
cure is great. 
 
 1. Strongly agree 
 2. Agree 
 3. Neither agree nor disagree 
 4. Disagree 
 5 Strongly disagree
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APPENDIX D: 
 
SPANISH CANCER RESPONSE EFFICACY  
 
[Breast only] Las siguientes oraciones se refieren a su inquietud de llegar a 
tener cáncer de seno. Para cada pregunta, circule la única respuesta que 
describa mejor sus sentimientos. 
 
1. Cuando el cáncer de seno se encuentra temprano, puede curarse. 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
2. Cuando una mujer se hace un examen de sus propios senos, puede detectar el 
cáncer en una fase temprana.  
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
3. Hacerse una mamografía le dirá a una mujer si tiene cáncer de seno. 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
4. Cuando un doctor examina los senos de una mujer, el examen le dirá a ella si 
tiene o no cáncer de seno. 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
5. Cuando una prueba de detección del cáncer de seno dice que algo está mal, hay un 
gran chance de cura.  
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 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
            5. No estoy de acuerdo en absoluto.
 
 
 
 
 
 
APPENDIX D (Continued) 
 
[Colorectal only] Las siguientes afirmaciones se refieren a su inquietud de 
llegar a tener cáncer colorrectal. Para cada pregunta, circule la única respuesta 
que describa mejor sus sentimientos. 
1. Cuando el cáncer colorrectal se encuentra temprano, puede curarse. 
 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
2. Cuando se encuentran pólipos(crecimientos) colorrectales y se quitan, el cáncer 
colorrectal puede prevenirse. 
 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
3. Hacerse una prueba de detección de cáncer colorrectal dice si una persona tiene 
cáncer colorrectal. 
 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto. 
 
4. Cuando los resultados de una prueba de detección de cáncer colorrectal dicen que 
algo está mal, hay una gran posibilidad de cura.  
 
 1. Estoy completamente de acuerdo. 
 2. Estoy de acuerdo. 
 3. Ni estoy de acuerdo ni en desacuerdo. 
 4. No estoy de acuerdo. 
 5 No estoy de acuerdo en absoluto.
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APPENDIX E: 
 
ENGLISH PERSONAL MASTERY SCALE 
Please circle the one response that describes how strongly you agree or 
disagree with these statements about yourself. 
   
 (1) (2) (3) (4) (5) 
                            Strongly   Agree   Neutral  Disagree   Strongly 
     Agree                   Disagree 
      
 
 
1.  There is really no way  1 2 3 4 5  
      I can solve problems I have.  
 
 
2.  Sometimes I feel that  1 2 3 4 5  
     I am being pushed around in life. 
 
 
3.  I have little control  1 2 3 4 5  
     over the things that happen to me. 
 
 
4.  I can do just about everything  1 2 3 4 5  
     I set my mind to do. 
 
 
5.  I often feel helpless in dealing 1 2 3 4 5  
     with the problems of life. 
 
 
6.  What happens to me in the 1 2 3 4 5  
    future mostly depends on me. 
 
 
7.  There is little I can do 1 2 3 4 5  
     to change many of the  
     important things in my life.
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APPENDIX F: 
 
SPANISH PERSONAL MASTERY SCALE 
 
Por favor haga un circulo alrededor la respuesta que describa lo que piensa 
(estas muy de acuerdo o no estas muy de acuerdo) sobre usted misma. 
                                                                     (1)              (2)         (3)          (4)              (5) 
           Estoy    Estoy             Estoy          Estoy en                 Estoy 
                                                              totalmente de       de acuerdo      neutral      desacuerdo        totalemente  
                                                                                                    acuerdo                                                                             en desacuerdo 
 
 
1.  En realidad no hay ninguna                     1     2       3          4      5 
     manera en que yo pueda solucionar  
     algunos de los problemas que tengo.  
 
 
2.  Algunas veces siento que estoy siendo   1      2       3          4      5 
      empujada por la vida.                                 
 
 
3.  Yo tengo muy poco control sobre          1      2       3          4      5 
     las cosas que me pasan.                                                                        
 
 
4.  Yo puedo hacer cualquier cosa si          1      2       3          4      5 
      en verdad me lo propongo.                           
 
 
5.  Con frecuencia me siento inútil          1      2       3          4      5 
      para confrontar los problemas de  
      la vida. 
 
 
6.  Lo que me pase en el futuro               1      2       3          4      5 
     depende en su mayor parte de mí.  
 
 
7.  Hay muy poco que yo pueda hacer         1      2       3          4      5 
     para cambiar muchas de las cosas  
     importantes en mi vida. 
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APPENDIX G: 
 
ENGLISH PATIENT HEALTH QUESTIONNAIRE –DEPRESSION MODULE 9 
 
Over the last 2 weeks, how often have you been bothered by any of the 
following problems? 
(Check one answer for each item.) 
 
 Not at 
all 
(1) 
Several 
Days 
 (2) 
More 
than half 
of the 
days (3) 
Nearly 
every day 
(4) 
1.  Little interest or pleasure in doing 
things 
⁯ ⁯ ⁯ ⁯ 
2.  Feeling down, depressed, or 
hopeless 
⁯ ⁯ ⁯ ⁯ 
3.  Trouble falling or staying asleep or 
     sleeping too much 
⁯ ⁯ ⁯ ⁯ 
4.  Feeling tired or having little energy ⁯ ⁯ ⁯ ⁯ 
5.  Poor appetite or overeating ⁯ ⁯ ⁯ ⁯ 
6.  Feeling bad about yourself— or 
that you are a failure or have let 
yourself or your family down 
⁯ ⁯ ⁯ ⁯ 
7.  Trouble concentrating on things 
such as reading the newspaper or 
watching television 
⁯ ⁯ ⁯ ⁯ 
8.  Moving or speaking so slowly that 
other people could have noticed?  Or 
the opposite—being so fidgety or 
restless that you have been moving 
around  
a lot more than usual 
⁯ ⁯ ⁯ ⁯ 
9.  Thoughts that you would be better 
off dead or of hurting yourself 
⁯ ⁯ ⁯ ⁯ 
10.  If you checked off any problems 
on this page, how difficult have 
these problems made it for you to 
do your work, take care of things 
at home, or get along with people? 
(please circle one answer) 
1. not difficult at all 
2. somewhat difficult 
3. very difficult 
4. extremely difficult 
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APPENDIX H: 
 
SPANISH PATIENT HEALTH QUESTIONNAIRE –DEPRESSION MODULE 9 
 
Durante las ultimas 2 semanas, con que frecuencia le han molestado los 
siguientes problemas? 
(Marque la respuesta correcta en frente de cada frase) 
 
 Nunca 
(1) 
Varios 
días 
(2) 
Más de 
la mitad 
de los 
días (3) 
Casi 
todos 
los días 
(4) 
1.  Tener poco interés o placer en hacer las 
cosas 
⁯ ⁯ ⁯ ⁯ 
2. Sentirse desanimada, deprimida, o sin 
     esperanza.                                                     
⁯ ⁯ ⁯ ⁯ 
3. Con problemas para dormirse o mantenerse
     dormida, o en dormir demasiado 
⁯ ⁯ ⁯ ⁯ 
4.  Sentirse cansada o tener poca energía ⁯ ⁯ ⁯ ⁯ 
5.  Tener poco apetito o comer en exceso.        ⁯ ⁯ ⁯ ⁯ 
6. Sentirse mal  acerca de uno misma o  
sentirse que es un fracaso o que se ha  
decepcionado a si misma o a su familia 
⁯ ⁯ ⁯ ⁯ 
7. Tener dificultad para concentrarse en cosas 
     como leer el periódico o ver televisión.       
⁯ ⁯ ⁯ ⁯ 
8. Se mueve o habla tan lentamente que otra 
 Gente se podría dar cuenta, o de lo contrario,
 está tan agitada o inquieta que se mueve 
 mucho más de lo acostumbrado.                      
 
⁯ ⁯ ⁯ ⁯ 
9. Ha pensado que seria mejor estar muerta o 
 en hacerse daño de alguna manera.          
⁯ ⁯ ⁯ ⁯ 
10. Si usted marco afirmativo (si) a 
cualquiera de los problemas en este 
cuestionario, cuán difícil se le ha hecho 
cumplir con su trabajo, atender su casa, o 
relacionarse con otras personas debido a 
estos problemas? (Por favor haga un circulo 
alrededor de una respuesta 
1.  Nada en absoluto  
2.  Un poco difícil 
3.  Muy difícil   
      4.  Extremamente difíci 
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APPENDIX I: 
 
ENGLISH SELF-EFFICACY MEASURE 
 
Follow up health care includes any additional doctor’s appointments and other tests that your 
doctor recommends.   
The following items ask whether you will be able to get follow up health care for the cancer 
screening that you recently received.  Please indicate how much you agree with the 
following statements.   
 Strongly 
Agree 
 
(1) 
Agree 
 
 
(2) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(4) 
Strongly 
Disagree 
 
(5) 
      
1.  I can get follow-up health care 
even if I am upset. 1 2 3 4 5 
      
2.  I can talk to my health care 
provider even if he or she does 
not speak my language. 
1 2 3 4 5 
      
3.  I can get transportation to 
health care appointments even 
if I cannot drive a car. 
1 2 3 4 5 
      
4.  I can have someone help me 
read health care materials if I 
have trouble reading. 
1 2 3 4 5 
      
5.  I can take time off work to go 
to health care appointments. 1 2 3 4 5 
      
6.  I can get follow-up health care 
even if I have to care for my 
family. 
1 2 3 4 5 
      
7.  I can get follow-up health care 
even if I am tired. 1 2 3 4 5 
      
8.  I can get follow-up health care 
even if my friends do not want 
me to. 
1 2 3 4 5 
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Follow up health care includes any additional doctor’s appointments and other tests that your 
doctor recommends.   
The following items ask whether you will be able to get follow up health care for the cancer 
screening that you recently received.  Please indicate how much you agree with the 
following statements.   
 Strongly 
Agree 
 
(1) 
Agree 
 
 
(2) 
Neither 
agree 
nor 
disagree 
(3) 
Disagree 
 
 
(4) 
Strongly 
Disagree 
 
(5) 
9.  I can get follow-up care even 
if I do not have immigration 
papers. 
1 2 3 4 5 
      
10.  I can get follow up health 
care even if I do not like my 
health care provider. 
1 2 3 4 5 
      
12.  I can get follow-up health 
care even if I believe that my 
life is in God’s hands. 
1 2 3 4 5 
      
13.  I can talk to my health care 
provider even if I have 
difficulty understanding him 
or her. 
1 2 3 4 5 
      
14.  I can get transportation to 
health care appointments 
even if I do not have a car. 
1 2 3 4 5 
      
15.  I can get follow-up health 
care even if I am not 
motivated to go to the clinic. 
1 2 3 4 5 
      
16.  I can fill out forms at the 
clinic even if I have trouble 
writing. 
1 2 3 4 5 
      
17.  I can take time off work to 
go to health care 
appointments even if I do 
not get paid. 
1 2 3 4 5 
      
18.  I can find someone to care 
for my family members so 
that I can attend clinic 
appointments. 
1 2 3 4 5 
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Follow up health care includes any additional doctor’s appointments and other tests that your 
doctor recommends.   
 
The following items ask whether you will be able to get follow up health care for the cancer 
screening that you recently received.  Please indicate how much you agree with the 
following statements.   
 Strongly 
Agree 
 
(1) 
Agree 
 
 
(2) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(4) 
Strongly 
Disagree 
 
(5) 
19.  I can find people who can help 
me get follow-up health care. 1 2 3 4 5 
      
20.  I can get follow-up health care 
even if I am worried. 1 2 3 4 5 
      
21.  I can get follow-up health care 
even if I am afraid to talk to 
my health care provider. 
1 2 3 4 5 
22.  I can get follow-up care even 
if I am not a United States 
citizen. 
1 2 3 4 5 
23.  I can get follow-up health care 
even if the process is 
uncomfortable. 
1 2 3 4 5 
      
24.  I can get follow-up health care 
even if I do not want to know 
if I am sick. 
1 2 3 4 5 
      
25.  I can get follow-up health care 
even if I am depressed. 1 2 3 4 5 
      
26.  I can get follow-up health care 
even if I do not know what 
questions to ask. 
1 2 3 4 5 
      
27.  I can get transportation to 
health care appointments even 
if there is no bus. 
1 2 3 4 5 
      
28.  I can talk to my supervisor 
about getting time off work to 
go to health care 
appointments. 
1 2 3 4 5 
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Follow up health care includes any additional doctor’s appointments and other tests that your 
doctor recommends.   
 
The following items ask whether you will be able to get follow up health care for the cancer 
screening that you recently received.  Please indicate how much you agree with the 
following statements.   
 
 Strongly 
Agree 
 
(1) 
Agree 
 
 
(2) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(4) 
Strongly 
Disagree 
 
(5) 
29.  I can get follow-up health care 
even if someone in my family 
does not want me to. 
1 2 3 4 5 
      
30.  I can get follow-up health care 
even if I am afraid that I may 
have cancer. 
1 2 3 4 5 
31.  I can get follow-up health care 
even if the process is scary. 1 2 3 4 5 
      
32.  I can ask for help to complete 
health forms even if they are 
in a different language. 
1 2 3 4 5 
      
33.  I can find people who can give 
me good advice about my 
health care. 
1 2 3 4 5 
34.  I can get follow-up health care 
even if I feel sick. 
1 2 3 4 5 
      
35.  I can talk to my supervisor 
about my health even if I am 
afraid that I will be fired. 
1 2 3 4 5 
      
36.  I can get follow-up health care 
even if a member of my family 
is upset about my health. 
1 2 3 4 5 
      
37.  I can get follow-up health care 
even if I have trouble talking 
to my health care provider. 
1 2 3 4 5 
      
38. I can find people who can help 
me read things that I do not 
understand. 
1 2 3 4 5 
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Follow up health care includes any additional doctor’s appointments and other tests that your 
doctor recommends. 
The following items ask whether you will be able to get follow up health care for the cancer 
screening that you recently received.  Please indicate how much you agree with the 
following statements.   
 Strongly 
Agree 
 
(1) 
Agree 
 
 
(2) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(4) 
Strongly 
Disagree 
 
(5) 
39.  I can get follow-up health care 
even if I have to wait a long 
time at the clinic. 
1 2 3 4 5 
      
40.  I can get follow-up health care 
even if I feel pain. 1 2 3 4 5 
      
41.  I can get to a health care 
appointment even if it is far 
away. 
1 2 3 4 5 
42.  I can find people who can 
help me get to my clinic 
appointments. 
1 2 3 4 5 
      
43.  I can get follow-up health care 
even if I do not feel sick. 1 2 3 4 5 
      
44.  I can get medicines even if I 
have trouble paying for them. 1 2 3 4 5 
      
45.  I can get follow-up health care 
even if I do not understand the 
health problem. 
1 2 3 4 5 
      
46.  I can get follow-up health care 
even if I have trouble paying 
for it. 
1 2 3 4 5 
      
47.  I can get follow-up health care 
even if I get frustrated with 
things that go wrong at the 
clinic. 
1 2 3 4 5 
      
48.  I can get follow-up health care 
even if I do not feel pain. 1 2 3 4 5 
      
49.  I can get follow-up health care 
even if I usually use natural 
remedies to treat disease. 
1 2 3 4 5 
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Follow up health care includes any additional doctor’s appointments and other tests that your 
doctor recommends. 
The following items ask whether you will be able to get follow up health care for the cancer 
screening that you recently received.  Please indicate how much you agree with the 
following statements.   
 
 Strongly 
Agree 
 
(1) 
Agree 
 
 
(2) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(4) 
Strongly 
Disagree 
 
(5) 
50.  I can get follow-up health care 
even if I feel hopeless. 1 2 3 4 5 
      
51.  I can get to a health care 
appointment that is in a place I 
have never been to. 
1 2 3 4 5 
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APPENDIX J: 
 
SPANISH SELF-EFFICACY MEASURE 
 
Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que 
su doctor recomienda. 
 
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de 
seguimiento después de las pruebas de detección de cáncer que se hizo 
recientemente. Circule la respuesta que indique en qué medida usted está de 
acuerdo con las siguientes oraciones. 
 
 Estoy 
completamente 
de acuerdo 
 
 
(1) 
Estoy de 
acuerdo 
 
 
 
(2) 
Ni estoy de 
acuerdo ni 
en des-
acuerdo 
 
(3)  
No estoy 
de 
acuerdo 
 
 
(4) 
No estoy 
de 
acuerdo 
en 
absoluto 
(5) 
      
1. Puedo obtener cuidados 
médicos de seguimiento 
incluso si estoy disgustado. 
1 2 3 4 5 
2. Puedo hablar con un 
profesional de la salud 
incluso si éste no habla mi 
idioma. 
1 2 3 4 5 
3. Puedo conseguir transporte 
para ir a las citas médicas 
incluso si no puedo manejar 
un auto. 
1 2 3 4 5 
4. Puedo pedirle a alguien que 
me ayude a leer los 
documentos médicos si 
tengo problemas para leer. 
1 2 3 4 5 
5. Puedo tomar horas libres en el 
trabajo para ir a mis citas 
médicas. 
1 2 3 4 5 
6. Puedo obtener cuidados 
médicos de seguimiento 
incluso si tengo que cuidar 
de mi familia. 
1 2 3 4 5 
7. Puedo obtener cuidados 
médicos de seguimiento 
incluso si estoy cansado. 
1 2 3 4 5 
8. Puedo obtener cuidados 
médicos de seguimiento 
incluso si mis amigos no lo 
quieren. 
1 2 3 4 5 
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que 
su doctor recomienda. 
 
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de 
seguimiento después de las pruebas de detección de cáncer que se hizo 
recientemente. Circule la respuesta que indique en qué medida usted está de 
acuerdo con las siguientes oraciones. 
 
 
 Estoy 
completamente 
de acuerdo 
 
 
(1) 
Estoy de 
acuerdo 
 
 
 
(2) 
Ni estoy 
de 
acuerdo 
ni en des-
acuerdo 
 
(3)  
No 
estoy de 
acuerdo 
 
 
(4) 
No 
estoy de 
acuerdo 
en 
absoluto 
(5) 
9. Puedo obtener cuidados médicos de 
seguimiento incluso si no tengo 
papeles de inmigración. 
1 2 3 4 5 
      
10. Puedo obtener cuidados médicos de 
seguimiento incluso si no me gusta 
el profesional de la salud. 
1 2 3 4 5 
      
11. Puedo obtener cuidados médicos de 
seguimiento incluso si estoy 
ocupado. 
1 2 3 4 5 
      
12. Puedo obtener cuidados médicos de 
seguimiento incluso si creo que mi 
vida está en manos de Dios. 
1 2 3 4 5 
      
13. Puedo organizar una cita para hablar 
con mi profesional de la salud 
incluso si tengo dificultad para 
entenderle. 
1 2 3 4 5 
      
14. Puedo conseguir transporte para ir a 
las citas médicas incluso si no 
tengo auto. 
1 2 3 4 5 
      
15. Puedo obtener cuidados médicos de 
seguimiento incluso si no estoy 
motivado para ir a la clínica. 
1 2 3 4 5 
      
16. Puedo llenar formularios en la 
clínica incluso si tengo problemas 
para escribir. 
1 2 3 4 5 
      
17. Puedo tomar horas libres en el 
trabajo para ir a citas médicas 
incluso si no me pagan. 
1 2 3 4 5 
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que 
su doctor recomienda. 
 
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de 
seguimiento después de las pruebas de detección de cáncer que se hizo 
recientemente. Circule la respuesta que indique en qué medida usted está de 
acuerdo con las siguientes oraciones. 
 
Estoy 
completamente 
de acuerdo 
 
 
(1) 
Estoy de 
acuerdo 
 
 
 
(2) 
Ni estoy 
de 
acuerdo 
ni en 
des-
acuerdo 
 
(3)  
No 
estoy de 
acuerdo 
 
 
(4) 
No 
estoy de 
acuerdo 
en 
absoluto 
(5) 
18. Puedo buscar a alguien que cuide de 
mi familia para que yo pueda asistir 
a las citas en la clínica. 
1 2 3 4 5 
      
19. Puedo encontrar a personas que me 
ayuden a obtener cuidados médicos 
de seguimiento. 
1 2 3 4 5 
      
20. Puedo obtener cuidados médicos de 
seguimiento incluso si estoy 
preocupado. 
1 2 3 4 5 
      
21. Puedo obtener cuidados médicos de 
seguimiento incluso si me asusta 
hablar con mi profesional de la 
salud. 
1 2 3 4 5 
      
22. Puedo obtener cuidados médicos de 
seguimiento incluso si no soy 
ciudadano de los Estados Unidos. 
1 2 3 4 5 
      
23. Puedo obtener cuidados médicos de 
seguimiento incluso si el proceso es 
incómodo. 
1 2 3 4 5 
      
24. Puedo obtener cuidados médicos de 
seguimiento incluso si no quiero 
saber si estoy enfermo. 
1 2 3 4 5 
25. Puedo obtener cuidados médicos de 
seguimiento incluso si estoy 
deprimido. 
1 2 3 4 5 
      
26. Puedo obtener cuidados médicos de 
seguimiento incluso si no sé qué 
preguntas hacer. 
1 2 3 4 5 
      
27. Puedo conseguir transporte para ir a 
las citas médicas incluso si no hay 
guagua (autobús). 
1 2 3 4 5 
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que 
su doctor recomienda. 
 
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de 
seguimiento después de las pruebas de detección de cáncer que se hizo 
recientemente. Circule la respuesta que indique en qué medida usted está de 
acuerdo con las siguientes oraciones. 
 
 
 
Estoy 
completamente 
de acuerdo 
 
 
(1) 
Estoy de 
acuerdo 
 
 
 
(2) 
Ni estoy 
de 
acuerdo 
ni en 
des-
acuerdo 
 
(3)  
No 
estoy de 
acuerdo 
 
 
(4) 
No 
estoy de 
acuerdo 
en 
absolut
o 
(5) 
28. Puedo hablar con mi supervisor 
sobre la posibilidad de tomar horas 
libres en el trabajo para ir a citas 
médicas. 
1 2 3 4 5 
      
29. Puedo obtener cuidados médicos de 
seguimiento incluso si alguien de 
mi familia no quiere que lo haga. 
1 2 3 4 5 
 
30. Puedo obtener cuidados médicos de 
seguimiento incluso si me da miedo 
que pueda tener cáncer. 
1 2 3 4 5 
      
31. Puedo obtener cuidados médicos de 
seguimiento incluso si el proceso 
me asusta. 
1 2 3 4 5 
      
32. Puedo pedir ayuda para llenar 
formularios de salud incluso si 
están escritos en un idioma distinto. 
1 2 3 4 5 
      
33. Puedo encontrar a personas que me 
den buenos consejos sobre el 
cuidado de mi salud. 
1 2 3 4 5 
      
34. Puedo obtener cuidados médicos de 
seguimiento incluso si me siento 
enfermo. 
1 2 3 4 5 
35. Puedo hablar con mi supervisor 
sobre mi salud incluso si tengo 
miedo de que me bote (despida). 
1 2 3 4 5 
36. Puedo obtener cuidados médicos de 
seguimiento incluso si alguien de 
mi familia está disgustado debido a 
mi salud. 
1 2 3 4 5 
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que 
su doctor recomienda. 
 
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de 
seguimiento después de las pruebas de detección de cáncer que se hizo 
recientemente. Circule la respuesta que indique en qué medida usted está de 
acuerdo con las siguientes oraciones. 
 
  Estoy 
completamente 
de acuerdo 
 
 
(1) 
Estoy de 
acuerdo 
 
 
 
(2) 
Ni estoy 
de 
acuerdo 
ni en des-
acuerdo 
 
(3)  
No estoy 
de 
acuerdo 
 
 
(4) 
No 
estoy de 
acuerdo 
en 
absoluto 
(5) 
      
37. Puedo obtener cuidados médicos de 
seguimiento incluso si tengo 
problemas para hablar con mi 
profesional de la salud. 
1 2 3 4 5 
38. Puedo encontrar personas que me 
pueden ayudar a leer cosas que no 
entiendo. 
1 2 3 4 5 
39. Puedo obtener cuidados médicos de 
seguimiento incluso si tengo que 
esperar mucho tiempo en la clínica. 
1 2 3 4 5 
40. Puedo obtener cuidados médicos de 
seguimiento incluso si siento dolor. 1 2 3 4 5 
41. Puedo ir a una cita médica incluso si 
está lejos. 1 2 3 4 5 
42. Puedo encontrar personas que 
pueden ayudarme a llegar a mis 
citas de la clínica. 
1 2 3 4 5 
43. Puedo obtener cuidados médicos de 
seguimiento incluso si no me siento 
enfermo. 
1 2 3 4 5 
44. Puedo obtener medicinas incluso si 
me es difícil pagarlas. 1 2 3 4 5 
45. Puedo obtener cuidados médicos de 
seguimiento incluso si no entiendo 
el problema médico. 
1 2 3 4 5 
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que 
su doctor recomienda. 
 
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de 
seguimiento después de las pruebas de detección de cáncer que se hizo 
recientemente. Circule la respuesta que indique en qué medida usted está de 
acuerdo con las siguientes oraciones. 
 
 
 Estoy 
completamente 
de acuerdo 
 
 
(1) 
Estoy de 
acuerdo 
 
 
 
(2) 
Ni estoy 
de 
acuerdo 
ni en des-
acuerdo 
 
(3)  
No 
estoy de 
acuerdo 
 
 
(4) 
No 
estoy de 
acuerdo 
en 
absoluto 
(5) 
46. Puedo obtener cuidados médicos de 
seguimiento incluso si me es difícil 
pagarlos. 
1 2 3 4 5 
47. Puedo obtener cuidados médicos de 
seguimiento incluso si me frustran 
las cosas que no van bien en la 
clínica. 
1 2 3 4 5 
48. Puedo obtener cuidados médicos de 
seguimiento incluso si no siento 
dolor. 
1 2 3 4 5 
49. Puedo obtener cuidados médicos de 
seguimiento incluso si 
normalmente uso remedios 
naturales para tratar las 
enfermedades. 
1 2 3 4 5 
50. Puedo obtener cuidados médicos de 
seguimiento incluso si he perdido 
las esperanzas. 
1 2 3 4 5 
51. Puedo ir a una cita médica que está 
en un lugar que no conozco. 1 2 3 4 5 
 
 
 
 
APPENDIX K: 
 
CONTENT VALIDITY REVIEWER INVITATION LETTERS 
 
Dear XXX, 
 
I’m currently conducting a thesis project entitled “Evaluating the psychometric 
properties of a self-efficacy measure within a Patient Navigator Research Project” under 
the supervision of Dr. Oliver Massey, director of the Division of Policy and Services 
Research and Evaluation at the Florida Mental Health Institute. The goal of my study is 
to examine the psychometric properties of a self-efficacy measure related to obtaining 
follow-up care after receiving results suspicious for cancer.  
The instrument was initially developed and pilot tested by an NCI-funded study 
titled “Patient Navigation Research Project.” A team of investigators developed the 
measure to assess participants’ perceived capability to obtaining follow up care after 
getting abnormal results suspicious for cancer. By conducting my research project, I hope 
to refine the instrument items and gather evidence of the instrument’s psychometric 
properties. In order to do that, I will conduct content validity assessments. As you know, 
content validity is an evaluation of whether items in a scale are relevant and measure all 
aspects of a construct.  
I would like to ask for your assistance in serving as a content validity reviewer 
based on your expertise on the topic of self-efficacy and your ample experience with 
instrument development. If you agree to take part, I will send you an email containing a 
brief rating form. The form asks for you to rate each item based on its relation to the 
underlying construct of self-efficacy, rate each item’s level of clarity and provide 
suggestions for revisions. This form takes about 15-20 minutes to complete. Once you 
have completed the form, I will ask you to return it to me electronically. Upon the 
completion of my thesis project, and if you are interested, I will be happy to provide you 
with a summary of the results and a copy of the final instrument.  
Thank you so much for considering my request for assistance with my thesis 
project. Please let me know your decision to participate at your earliest convenience.  
Please feel free to contact me should you have any questions regarding the content 
validity evaluation or my project.   
 
Sincerely,  
 
 
 
Mariana Arevalo 
MPH candidate, Community and Family Health  
University of South Florida
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APPENDIX K (Continued) 
 
Dear XXX, 
 
I’m currently conducting a thesis project entitled “Evaluating the psychometric 
properties of a self-efficacy measure within a Patient Navigator Research Project” under 
the supervision of Dr. Oliver Massey, director of the Division of Policy and Services 
Research and Evaluation at the Florida Mental Health Institute. The goal of my study is 
to examine the psychometric properties of a self-efficacy measure related to obtaining 
follow-up care after receiving results suspicious for cancer.  
The instrument was initially developed and pilot tested by an NCI-funded study 
titled “Patient Navigation Research Project.” A team of investigators developed the 
measure to assess participants’ perceived capability to obtaining follow up care after 
getting abnormal results suspicious for cancer. The measure was developed in English 
and Spanish language. By conducting my research project, I hope to refine the instrument 
items and gather evidence of the instrument’s psychometric properties. In order to do 
that, I will conduct content validity assessments. As you know, content validity is an 
evaluation of whether items in a scale are relevant and measure all aspects of a construct.  
I would like to ask for your assistance in serving as a content validity reviewer 
based on your expertise on the topic of self-efficacy, your ample experience with 
instrument development, and your ability to speak Spanish fluently. If you agree to take 
part, I will send you an email containing a brief rating form. The form asks for you to rate 
each item based on its relation to the underlying construct of self-efficacy, rate each 
item’s level of clarity and provide suggestions for revisions. This form takes about 15-20 
minutes to complete. Once you have completed the form, I will ask you to return it to me 
electronically. Upon the completion of my thesis project, and if you are interested, I will 
be happy to provide you with a summary of the results and a copy of the final instrument.  
Thank you so much for considering my request for assistance with my thesis 
project. Please let me know your decision at your earliest convenience.  Please feel free 
to contact me should you have any questions regarding the content validity evaluation or 
my project.   
 
Sincerely,  
 
 
 
Mariana Arévalo 
MPH candidate, Community and Family Health  
University of South Florida
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APPENDIX L: 
 
ENGLISH CONTENT VALIDITY EXPERT SCORING CARD 
 
INSTRUCTIONS:  This form is designed to evaluate the content validity of an 
instrument measuring self-efficacy for obtaining follow-up care after receiving an 
abnormality suspicious for cancer.   
Construct of interest: Self-efficacy is an individual’s perceived capacity to execute a 
desired behavior.  
Please rate each item as follows: 
 Column 1: Please rate the level of each item’s relevance to the construct of interest on 
a scale of 1-4, where 1= “Not relevant at all” 2= “Slightly relevant” 3=“Somewhat 
relevant” 4 =“Relevant” as it relates to the construct of self-efficacy. 
o The space provided is for you to comment on the item or to suggest 
revisions 
 Column 2: Please indicate the level of clarity for each item also on a 4-point scale, 
where 1= “Item is not clear” 2= “Item needs major revisions to be clear”; 
3=”Item needs minor revisions to be clear”; 4= “Item is clear” 
 Column 3: Finally, please evaluate the comprehensiveness of the entire instrument by 
indicating items that should be deleted based on redundancy, cultural or linguistic 
acceptability.  
Thank you for your time.  
 
ITEM 
1= Not relevant at all  
2= Slightly relevant  
3=Somewhat relevant  
4 =Relevant 
1= Item is not clear  
2= Needs major 
revisions to be 
clear  
3=Needs minor 
revisions to be 
clear 
4= Item is clear 
Other comments 
or suggestions to 
delete items 
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APPENDIX M: 
 
SPANISH CONTENT VALIDITY EXPERT SCORING CARD 
 
INSTRUCCIONES:  El siguiente formulario fue diseñado para evaluar la validez del 
contenido de un instrumento que mide el nivel de autoeficacia de una persona al obtener 
cuidados médicos de seguimiento después de obtener resultados anormales en una prueba 
de detección del cáncer.    
El dominio de interés del instrumento es la autoeficacia, la cual es la capacidad de una 
persona para ejecutar un comportamiento deseado.  
Por favor califique cada ítem del instrumento de la siguiente forma: 
 Columna 1: En una escala de 1 a 4, por favor indique el nivel de relevancia de cada 
ítem con respecto al dominio de interés (i.e. autoeficacia) tomando en cuenta los 
siguientes valores: 1= “No tiene relevancia”; 2= “Es poco relevante” 3=“Es algo 
relevante” 4 =“Es relevante.”  
o El espacio en blanco bajo cada cuadro puede ser utilizado para escribir sus 
comentarios acerca de cada ítem ó para sus sugerencias acerca de éste.  
 Columna 2: De forma similar en una escala de 1 a 4, por favor indique el nivel de 
claridad de cada ítem utilizando los siguientes valores: 1= “ítem no es claro” 2= 
“ítem necesita correcciones/ajustes mayores para ser claro”; 3= “ítem necesita 
correcciones/ajustes menores para ser claro”; 4= “ítem es claro” 
 Columna 3: Finalmente, por favor evalúe la complejidad del instrumento indicando si 
considera que algún ítem deberia de ser eliminado por ser redundante ó por falta de 
consideración de cuestiones culturales o linguisticas.  
Muchas gracias por su tiempo.  
ítem 
1= No tiene relevancia 
2= Es poco relevante 
3= Es algo relevante 
4 =Es relevante 
1= ítem no es claro 
2= ítem necesita 
correcciones/ajustes 
mayores para ser claro 
3= ítem necesita 
correcciones/ajustes 
menores para ser claro 
 4=ítem es claro 
Otros comentarios 
o sugerencias 
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APPENDIX N: 
 
QUALITATIVE DATA FROM CONTENT VALIDITY RATING FORM 
 
Table A. Comments gathered from content validity reviewers (English and Spanish combined) 
item  COMMENTS COMMENTS 
# Item Description English Spanish 
2 
I can talk to my health care 
provider even if he or she 
does not speak my 
language. 
 this is related to SE, but this is depending on factors 
outside of the individual’s control (i.e. interpreter). 
This may be tricky.  
 I would be helpful to know the response options for 
the questions. I am assuming they are rating their 
confidence on a likert-type scale; item is clear but 
I’m not sure it makes sense. If he or she doesn’t 
speak (and I’m assuming understand, too) the 
language, what does it mean to “talk” to them? 
 I would remove this item. OR, at the very least 
consider changing it to talk with, if you do in fact 
want to imply a conversation. 
 Is this supposed to be in Spanish?  
 Should the focus be the use of an interpreter? 
Reword to: I can request an interpreter if my PCP 
does not speak my language 
 They do not speak the same language 
 Why is the word “talk” used in one sentence and 
“speak in the other? I think the concept is to 
communicate – is it possible to communicate? 
 Aclarar: puedo encontrar la manera 
para comunicarme con un… 
o 4. Consider using aunque 
instead of incluso si 
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Table A. Comments gathered from content validity reviewers (English and Spanish combined) 
item  COMMENTS COMMENTS 
# Item Description English Spanish 
3 
I can get transportation to 
health care appointments 
even if I cannot drive a car. 
 
 You make assumptions. Perhaps best to 
say do you have transportation Yes/No. 
If no, how do you get to your medical 
visits… that way you get more 
information. 
 Explicar como, “Puedo recurrir a 
recursos locales y conseguir…” o 
“puedo recurrir a mis familiars” 
 Consider using aunque instead of 
incluso si 
13 
I can talk to my health care 
provider even if I have 
difficulty understanding him 
or her. 
 You may still leave the appointment without the 
necessary information. Consider rewording.  
 Consider changing it to “talk with” if you do, in fact, 
want to imply a conversation. I can talk to anybody 
regardless of whether or not I understand them. 
 Is this different than language question? Is this 
getting at medical terms? 
 Same as #2 
 Again, I think the construct is communication not 
“talk” 
 What do you mean “organizar” do you 
mean hacer? 
 “incluso” parts are wordy. Perhaps 
rephrase it.  
 Porque razón? Debido al idioma? 
Debido a los terminus medicos?  
  Consider using aunque instead of 
incluso 
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Table A. Continued 
item  COMMENTS COMMENTS 
# Item Description English Spanish 
16 
I can fill out forms at the 
clinic even if I have trouble 
writing. 
 Delete. Someone may have trouble writing because 
they cannot speak the language. 
 Not sure about this. Consider removing. Filling out 
forms is not essential to follow-up care (although 
providers want patients to do it). Furthermore, what 
do you mean “trouble writing” Do you mean it is 
difficult to move hands in a way that allows me to 
write clearly?” or “I don’t know how to construct a 
sentence” or “I don’t know how to spell?” or 
“something else?” 
 Trouble writing, is this intended to be a literacy 
skill-related item? Reword to; I’m unable to write. 
 Reading or writing 
 I wonder if people who have trouble writing would 
describe it like that? Maybe it is difficulty writing 
not “trouble” 
 
 This implies that they have someone 
that can help them – why not ask if 
they have someone that can help them. 
 existe mucho analfabetismo en la 
población latina hay que aclarar esto. 
“Puedo encontrar la manera de llenar 
formularios” 
 “unique no puedo escribir muy bien” 
27 
I can get transportation to 
health care appointments 
even if there is no bus. 
 Delete. Similar to above and below. 
 Assumes that some people can’t walk or take a taxi. 
 May be add “van” or “taxi” and if this is going 
outside of FL I would add “train, subway” 
 Public transportation 
 Redundant. Similar to # 3  Combine or 
choose one or the other. 
 Duplicate again 
 Consider using aunque instead of 
incluso 
41 
I can get to a health care 
appointment even if it is far 
away. 
 Delete. Similar to above. 
 Far is a relative term in urban vs rural settings 
 Consider merging with question #51. 
 Maybe say “not within walking distance” 
 Consider using aunque instead of 
incluso 
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Table A. Continued 
item  COMMENTS COMMENTS 
# Item Description English Spanish 
42 
I can find people who can 
help me get to my clinic 
appointments. 
 Consider prefacing (or ending) this question with “if 
needed”, since some people won’t need help getting 
to appointments. 
 Just because you can find them doesn’t mean that 
they would help. 
 Is the idea to find people or to have a network of 
people who can assist? 
 
44 
I can get medicines even if I 
have trouble paying for 
them. 
 This is relevant to SE, but also contingent upon so 
many other factors. Usually you have to be income 
eligible to get assistance. What about those who are 
above the threshold? 
 Strictly speaking, your definition of follow-up care 
did not include medications 
 If someone can’t pay for medicines, this is an issue. 
 Reword to: even if I cannot afford to pay for it. 
 Pair with 46 
 May be some of these questions should start saying 
“I know how to”? 
 
 Wording seems odd. 
  Puedo recurir a recursos locales para 
obtener… 
 Aunque se me haga… 
45 I can get follow-up health 
care even if I do not 
understand the health 
problem 
 Again, so what if you can, will you? 
 Would someone get follow-up for something they 
don’t understand? 
 Change to “my health problem” 
 “Puedo pedir explicaciones si no 
entiendo el problema medico que 
tengo/padezco.” 
 Consider using aunque instead of 
incluso 
46 
I can get follow-up health 
care even if I have trouble 
paying for it. 
 Again a lot of contingencies. 
 Again, so what if you can, will you? 
 Relevant 
 Reword to: even if I cannot afford to pay for it. 
 I’m not crazy about the word “trouble” may be 
difficulty? 
 Consider using aunque instead of 
incluso; also, awkward phrasing, 
consider “se me hace dificil” 
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Table A. Continued 
item  COMMENTS COMMENTS 
# Item Description English Spanish 
47 
I can get follow-up health 
care even if I get frustrated 
with things that go wrong at 
the clinic. 
 Is frustrated a universal term. Consider rewording.  
 Again, so what if you can, will you? 
 Frustration is culturally nuanced term,  frustrated 
because of language barriers could be different that 
other reasons 
 Is this question related to the quality of care received 
at the clinic? Too much waiting time, unhappy about 
quality of services, etc. Delete. 
 Maybe different than frustrated/ also frustrated is 
kind of vague. 
 The can word is problematic – technically can 
means able to but not necessarily will. For example, 
I can count to ten in other languages, but I won’t do 
it. I think you want to know if people will do things, 
not if they can.  
 Can you give examples for “van bien 
en la clínica”  
 el funcionamiento o proceso de la 
Clinica 
 Consider using aunque instead of 
incluso 
49 
I can get follow-up health 
care even if I usually use 
natural remedies to treat 
disease. 
 I would list examples of natural remedies or other 
terms like “herbal treatments?” to be clear what you 
mean. You might also say “even if usually use only 
natural remedies” 
 Follow-up care wouldn’t be denied if someone using 
the natural remedies implies such in question.  
 Not sure if you really need this. 
 I will get…. 
 4. Consider using aunque instead of 
incluso 
51 
I can get to a health care 
appointment that is in a 
place I have never been to. 
 Note that this one of only two questions, I think, that 
do not contain  “even if” 
 Good question, maybe revise wording, “that is in a 
location new to me”  
 This sentence is very grammatically incorrect. It 
should read “ I can get to a health care appointment 
in a place I have never been.” 
  
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APPENDIX O: 
 
REVISED ENGLISH-LANGUAGE ITEMS 
 
Table B. Revised English-language items 
 
Variable Original item Comments/suggestions Revised item 
bse44 
I can get medicines 
even if I have trouble 
paying for them. 
Substitute “trouble” for “difficulty” 
 
I can get medicines even if I 
have difficulty paying for 
them. 
bse46 
I can get follow-up 
health care even if I 
have trouble paying for 
it. 
Substitute “trouble” for “difficulty” 
 
I can get follow-up health 
care even if I have difficulty 
paying for it. 
bse3 
I can get transportation 
to health care 
appointments even if I 
cannot drive a car.  
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Table B. Continued 
Variable Original item Comments/suggestions Revised item 
bse27 
I can get transportation 
to health care 
appointments even if 
there is no bus. 
Add “van” or “taxi” and perhaps 
“train and subway”for cities outside of 
Florida 
I can get to my health care 
appointments even if there 
is no public transportation 
(bus, train, subway, etc). 
bse42 
I can find people who 
can help me get to my 
clinic appointments. 
  
bse41 
I can get to a health 
care appointment even 
if it is far away. 
Far is relative term in urban vs rural 
settings 
I can get to a health care 
appointment even if it is not 
within walking distance. 
bse47 
I can get follow-up 
health care even if I 
get frustrated with 
things that go wrong at 
the clinic.  
  
bse51 
I can get to a health 
care appointment that 
is in a place I have 
never been to. 
This sentence is very grammatically 
incorrect. Revise. 
I can get to a health care 
appointment in a place I 
have never been. 
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Table B. Continued 
Variable Original item Comments/suggestions Revised item 
bse13 
I can talk to my health 
care provider even if I 
have difficulty 
understanding him or 
her. 
Is this different than language 
question? Is this getting at medical 
terminology?  
I can ask questions to my 
health care provider if I 
have difficulty 
understanding him or her. 
bse2 
I can talk to my health 
care provider even if 
he or she does not 
speak my language. 
Should the focus be the use of an 
interpreter? 
I can request an interpreter 
if my health care provider 
does not speak my 
language. 
bse16 
I can fill out forms at 
the clinic even if I 
have trouble writing. 
Someone may have trouble writing 
because they cannot speak the 
language or because they are injured 
I can fill out forms at the 
clinic even if I am unable to 
write. 
bse45 
I can get follow-up 
health care even if I do 
not understand the 
health problem. 
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APPENDIX P: 
 
REVISED SPANISH-LANGUAGE ITEMS 
 
Table C. Revised Spanish-language items 
 
 
Variable Original item Comments/suggestions Revised item 
bse44 
Puedo obtener 
medicinas incluso si 
me es difícil pagarlas 
Wording seems odd.  
Reword to: aunque se me haga 
Puedo conseguir medicinas aunque me sea 
difícil pagarlas 
bse46 
Puedo obtener 
cuidados médicos de 
seguimiento incluso si 
me es difícil pagarlos 
Awkward phrasing. Consider using “se 
me hace difícil” 
Puedo obtener cuidados médicos de 
seguimiento aunque se me haga difícil 
pagarlos 
bse3 
Puedo conseguir 
transporte para ir a las 
citas médicas incluso 
si no puedo manejar un 
auto 
Consider using aunque instead of 
incluso si 
Puedo conseguir transporte para ir a las citas 
médicas aunque no pueda manejar un auto 
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Table C. Continued 
 
Variable Original item Comments/suggestions Revised item 
bse27 
Puedo conseguir 
transporte para ir a las 
citas médicas incluso 
si no hay guagua 
(autobús). 
Revised based on English revisions 
Puedo llegar a mis citas médicas aunque no 
haya transporte público (autobús, tren, tren 
subterráneo, etc.). 
bse42 
Puedo encontrar 
personas que pueden 
ayudarme a llegar a 
mis citas de la clínica 
  
bse41 
Puedo ir a una cita 
médica incluso si está 
lejos 
Revised based on English item Puedo ir a una cita médica aunque no esté en un lugar a donde me pueda ir a pie 
bse47 
Puedo obtener 
cuidados médicos de 
seguimiento incluso si 
me frustran las cosas 
que no van bien en la 
clínica. 
Consider using aunque instead of 
incluso si 
Puedo obtener cuidados médicos de 
seguimiento aunque me frustran las cosas 
que no van bien en la clínica. 
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Table C. Continued 
 
Variable Original item Comments/suggestions Revised item 
bse13 
Puedo organizar una 
cita para hablar con mi 
profesional de la salud 
incluso si tengo 
dificultad para 
entenderle. 
Revised based on English revisions 
 
Puedo hacerle preguntas a mi profesional de 
la salud si tengo dificultad para entenderle. 
bse2 
Puedo hablar con un 
profesional de la salud 
incluso si éste no habla 
mi idioma 
Revised based on English revisions Puedo pedir un intérprete si mi profesional de la salud no habla mi idioma 
bse16 
Puedo llenar 
formularios en la 
clínica incluso si tengo 
problemas para 
escribir 
Revised based on English revisions Puedo llenar formularios en la clínica aunque no sepa escribir 
bse45 
Puedo obtener 
cuidados médicos de 
seguimiento incluso si 
no entiendo el 
problema médico 
…problema médico que tengo/padezco 
Puedo obtener cuidados médicos de 
seguimiento aunque no entienda el 
problema médico que tengo 
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APPENDIX Q: 
 
INSTITUTIONAL REVIEW BOARD APPROVAL LETTER 
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